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OBJECTIVES
It Is now an established fact that purines, or 
the derived nucleosides, are the biogenetic precursors of 
riboflavin and probably also of other pteridines. This 
thesis describes the synthesis of possible intermediates 
in the above transformation, and an investigation of the 
chemical transformation of these compounds into riboflavin 
and other simpler pteridines*
Â preliminary study of the ring^opening reactions 
of guanos ine was also undertaken since ring «-cleavage of 
the purine is probably the initial step in the above 
transformation*
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SUMMRY
The evidence in the literature relating to the 
biosynthesis of riboflavin and of other simpler pteridines is 
reviewed. Possible intermediates in the transformation of 
purines into pteridines are discussed and the chemistry of some 
of these compounds has been investigated. The key intermediate 
appears to be l-[2',6*=dihydroxy-5*=nitro=4'-pyrlmidinylamino]~ 
l-deoxy-D-erythropentulose which could be formed by Amadori 
rearrangement of a substituted diaminopyrimidine glycoside*
This intermediate has been synthesised by the condensation of 
4-chloro-2,6-dihydroxy-5=nitropyrimidine with 1-amino»1-dooxy- 
D-erythropentulose. Stereospecifio reduction of the carbonyl 
group in the side-chain of this pyrimidine was achieved giving 
2e6-dihydroxy»5-nitro=4-D-ribitylaminopyrimidine which on 
subsequent reduction of the 5-nitro group and condensation with 
the dimer of 3,4-dimethyl-0;*benzoquinone gave riboflavin. Proof 
of the stereospeoific reduction was supplied by unambiguous 
synthesis of both pyrimidine isomers. Model experiments using 
l-[2•,6*-dihydroxy-5'-nitro-4'-pyrimidlnylamino]-l-deoxy-D= 
fructose are also described. The implications of these reactions 
in the biosynthesis and synthesis of riboflavin are discussed.
Oxidative self-condensation and condensation with alloxan 
of 5-amlno-2p6-dihydroxy-4-8ubstituted aminopyrimidines gave 
2*10-dlhydro-2-oxo-l0-8ub8tituted-4p6#6-trihydroxypyrimldo[5,4-g] 
pteridines.
The conversion of the key intermediate, l-[2*,6*- 
dihydroxy-5•-nitro-4*-pyrimidinylamino]-X-deoxy-D-erythropentulose 
to simple pteridines was also investigated. Thus, reduction of 
the 5-xiltro group of the model, l-[2•,6*-dihydroxy-5*-nitro°4*- 
pyrimidinylamlnoJ-l-deoxy-B-fructose, and intramolecular condensa­
tion followed by oxidation of the resulting dIhydropteridine, 
gave the 2-hydroxy analogue of xanthopterin and not the expected 
6-polyhydroxyalkylpteridine. Model experiments using 4~ac*tonyl= 
amino-2,6-dihydroxy-5-nitropyrimidine are also described. The 
hydrazine derivative of this model pyrimidine gave 2,4-dihydroxy- 
6-methylpteridine directly, but attempts to apply this technique 
to sugar containing pyrimidine were not successful.
4-Acetonylamino-2,6-dihydroxy-5-nitropyrimidine and 
2;6-dihydroxy-4-2*-hydroxyethylamino-5-nitropyrlmidine underwent 
an unusual intramolecular condensation to give imidazo[l,2-c] 
pyrimidine derivatives.
Alkylation of guanosine using benzyl bromide, gave a 
crystalline quaternary salt which on subsequent treatment with 
dilute alkali underwent cleavage of the imidazole ring to give 
a 5~aBino-4-D-ribo8ylamlnopyrimidine derivative.
An attempt to synthesise this glycoside directly proved 
unsuccessful as the product was suspected of undergoing an 
Amadori rearrangement.
I N T R O D U C T I O N■ ■ K s a B K a B M a E a c a c *a e f l( ts a B V S = a i= s s = a > n
It is only within the last twenty years that a systematic 
study has been made of.the naturally occurring pteridines«
Early investigations in this field were carried out» however» 
by Gowland-Hopkins^ as long ago as 1890. These compounds are 
widely distributed throughout the animal and plant kingdom, and 
they range from simple pigments to highly complex growth factors
Xanthopterin* which is the yellow colouring matter
3present in wasps, and leucopterin» which is the white pigment 
present in the wings of cabbage butterflies, are two such 
pigments. It is possible that these pteridines are degradation 
products of some more highly complex pteridine systems involved 
in the metabolism or growth of these insects.
O H
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Xanthopterin Leucopterin
4It is known that all mammalian cells make use of a 
pteridine which is a derivative of folio acid in order to 
divide. This substance is known as the •citrovorum factor*' 
and has been the subject of Intensive study.
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Most naturally occurring pteridines have 2-amino and
4-hydroxy groups attached to the parent nucleus. The latter 
group chelates readily with bivalent metals and it is probable 
that many pteridines exist in biological systems as metallic 
complexes such as that shown below.
*Riboflavin, which can be regarded as a benzojpteridine, 
is a universally distributed vitamin, probably existing in 
small amounts l^ n every animal and plant organism, some of
e *7which produce it in relatively large quantities.
Riboflavin is mainly found in flavin-adenine dinuclootide
(PAD), the prosthetic group of a flavo-protein enzyme, where
8it can readily be reduced to give a leuco compound. This
redox reaction reverses .with ease» and hence riboflavin derives 
its biological activity from the fact that it is a hydrogen 
carrier in these enzymes*
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As riboflavin contains one free hydroxy group in tho
heterocyclic nucleus» it resembles 8-hydroxyqulnoline in its
' 9ability to chelate with bivalent metallic ions. It is known
, 10to chelate with Fe (Itl) in enzyme systems and such 
systems function as dehydrogenases*
BIOSYNTHKSIS OF PTERIDINESI =: as «S s  sc ■( s  :
Comparison of the structural formulae of the naturally 
occurring purines, pteridines, and flavins, shows a striking 
resemblance particularly as each incorporates in its nucleus 
the skeleton of a diaminopyrimidineo This is shown clearly 
in the examples given below. This similarity seems to suggest 
a biological relationship between these groups of compounds.
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G-Compound* (II)
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(H » NHg, Guanosine: (III) (R - OH, Xanthoaine* (IV)
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Biopterin: (V)
Albert was the first to suggest that the purines, or 
their derived nucleosides, were the biosynthetic precursors of
pteridines. A similar suggestion relating to the biosynthesis
1 2of riboflavin had been made earlier by MacLaren and this will 
be discussed later in this thesiso Albert suggested that the 
imidazole ring of the purine opens to give a 4p5*diaraino- 
pyrimidine derivative with loss of Cgp and subsequent condensation 
with a two carbon fragment to give the pteridine ring structureo 
This is illustrated belowo The numbering of the various ring 
systems is also shown.
3 >
4
7
purine pyrimidine pteridine
Albert** was able to demonstrate the ^  vitro transforma­
tion of 2-hydroxypurine (ITI) to 2-hydroxypteridino (VIl). In 
this case the imidazole ring opehs at pH3 and 20* to give 
4~amino-5-formamido-2-hydroxypteridin©. The latter compound 
loses its formyl group at pH2 to give a 4,3-diaminopyrimidin@o 
Condensation with glyoxal then gives 2-hydroxypteridine in the 
usual way.
oH
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In this transformation Cg of the purine has been lost
as formic acid and Cg and Cy of the pteridine have been obtained
from the dicarbonyl derivative.
Biochemical evidence for the existence of diaraino-
pyrimidines as possible intermediates, came from the work
13Ziegler-Gunder ej^  al. who injected the larvae of the
r 1amphibian Xenopus intradermally with guanine [2- CJ* Ten days 
later, the skins of the sacrificed larvae, were extracted with 
N-ammonia solution at 20*. Paper chromatograms of the extract 
yielded blue fluorescent spots, one of which, on oxidation, 
was converted to labelled 2-amino-4-hydroxypteridine-6-carboxylic 
acid.
Further biochemical evidence was supplied by Weygand14
14who administered 2,4,5-triamino-6-hydroiypyrimidine [2* C] to
pierid caterpillars in their diet, and later isolated labelled
xanthopterin (VIIl) from the wings of the adult butterflies.
16Weygand also inoculated 3-4 day old cocoons of 
Pieris brasslcae with glucose [2- C] and found that a 78^ 
recovery of the label was obtained in carbon atoms 6 and 7 of 
the resulting leucopterin (IX). A similar experiment using 
ribose [l=^  C] gave a 64^ recovery of the label.
OH OH
N HH-
HO
I X
Prom these two observations, Weygand postulated that, 
in the above biological oystemg a pyrimidine glycoside 5*“ 
phosphate (X) could exist, which could undergo an Amadori 
rearrangement to give the pyrimidine (Xl). Intramolecular ring
closure would then yield a pteridine (XIl). He postulated
that subsequent oxidation of this pteridine caused it to lose 
its polyhydroxyalkyl side chain and give xanthopterin (VIIl). 
Addition of a molecule of water and further oxidation would then 
give leucopterin (lX)o
OH OH
© O . C H i
M HNH
C H j O ©
feHOH)»
8
OH
: “ T O
OH OH
H M
CM  ^CO(CHOm)  C H jO ®
7\
H H i
JÔÎ
I
VIIl
u>Kere. ©  *
16
Recently Remboldt hae succeeded in condensing 
D-riboae with 2,4-diamino=6=hydroxypyrimidine to give the
glycoside (XIII). This now makes possible a chemicalOH
OH
D-Rlbose ->
HO. CH%
NHH N
OH OH
XIII
synthesis of the glycoside (X), but this is not discussed 
further in this thesis.
Details of the biosynthesis of the more important 
naturally occurring pteridines# will now be summarisedo
17Folic Acide
The folic acid (pteroylglutamic acid) molecule (XIV) 
contains three parts# those of L-glutamic sold, p-aminobensoic 
acid-and a substituted pteridine»
C O » H  tOiM f
Suggestions for the biosynthesis of this molecule have 
been based on the hypothesis that the three residues are 
separately synthesised and then put together» The biologically 
active form of folic acid contains a reduced pyrazine ring and# 
although its precise chemical nature is yet unknown# it is 
thought to be a 5#6,7,8-tetrahydropteridine derivative. This 
active form is known as coenzyme F (CoF)# and it is concerned 
with the transfer of 1-carbon atom units in vivo.
One of the earliest theories was that folic acid arose 
from 2#4#5*triamino-6-hydroxypyrimidine (XV)# a ) carbon compound 
(reductone: XVI)# and p-aminoben%oylglutamic acid (XVII)^
These constituents will combine in the test tube to give folic
acid, but there Is no biological evidence for the validity of 
thie theory.
OH
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19Tscheache and Korte on the basis of growth experiments
Îwith 2  faecalis presented a scheme shown below, and Korte e_t al 
adduced evidence for this scheme showing that isoxanthopterin 
carboxylic acid [4-^  C] (XVIII) is converted to a compound or 
compounds which can be degraded to 2-amino-4-hydroxy-6-carboxy 
pteridine (XIX).
30
OH
i L ^  Jsox/»f|THOPtlC«W(^^
C4A80XYLIC—  AcioXVIII
HO
OH
ON
I
G r k y c o & i O C  •
f
I SCMiPf 6 4 & E  will» 
D - A M ( N 0  8 E H Z O Y L
G r t O T H m o  4 c i O  
& L y c o & i o 6
f o M O  4&10 XIX
A simple production of 'tfolic acid-like compounds" has
21recently been achieved by Shiota who has shown that tetrahydro- 
2=amino-4-hydroxy«=6-hydroxymethylpteridirie (XX) is converted by 
Loarabinosus extracts in the presence of ATP and magnesium, to 
materials giving a microbiological assay for folic acid.
p-Aminobenzoyl
Glutamic Acid Folic Acid *
or
p-Aminobenzoic Like CompoundsAcid
OH
XX
Biopterin
It is, however, very interesting that the reduced compound 
is much more active than the non-reduced material, indicating 
again that biosynthesis in this organism, at least, may proceed 
to give reduced compoundso 
°°Q-Compound”.
2,6-D ihy d ro «4-hy d r o xy - 6,7-d ime t hy 1 - 2 - ox o-8-D-r ib i tyl «=
pteridine (Masuda«s ^G-compound*^ ) ( 11$ R ® D-ribityl) was first
isolated together with riboflavin from cultures of Eremothecium
22ashbyii by Masuda, and subsequently by other workers from
various organisms. The structure of this compound was confirmed 
23 »2 4by synthesis which involved the condensation of biacetyl
(XXI) and 5-amino=4-D-ribitylamino-uracil (XXIIi R - D-ribityl).
12
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From the work to be described in the section dealing with
the biosynthesis of riboflavin, it will be apparent that
G-compound is formed vivo from a purine precursor by lose
of Cq , and subsequent condensation with biacetyl as in the
chemical synthesis above*
**Y-Compound .
7 » 8-Dihydro-2,4~dihydroxy-6=methyl-7-o%o-8=D-ribityl-
pteridine (lîasuda's »• V-compound** ) (XXIIIg R ■ D-ribityl) was
28also isolated from cultures of Eremothecium ashbyii by Masuda« 
Chemical proof of the structure again rests on synthesis 
which was achieved by condensation of pyruvic acid (XXIV) and
5-amino-4-D-ribitylamino-uracil (XXII* R - D-ribityl) as shown 
below.
OH r
M, H  ^
OH: X X r  . W .w I I
  R  ______  R _______X X W  XXII XXIII
2 6 —  -Biochemical experiments show that V-oompound is 
formed vivo from G-compoimd# and this has been attributed
2 9to simple oxidation of the methyl group at in pteridine 
. 3 0(II). Recently, Wood et al. have suggested a more reasonable 
method for this transformation. The pteridine (11$ R - D<=ribityl) 
became hydrated in alkaline solution to give a dihydropteridine 
(XXV# R ■ D-ribityl) which is a carbinolamine and probably exists 
in equilibrium with the pyrimidine (XXVI; R » D-ribityl)* 
Displacement of the biacetyl residue by pyruvic acid, occurred 
readily on gentle reflux to give V-compound (XXIII# R - D-ribityl)o 
It seems likely that such a mechanism could operate under 
biological-type conditions.
■^ 4
OH
t
OH
M e OH IRi OH
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Bioptorin,
This polyhydroxyalkyIpteridine has been obtained from 
two natural sources, (a) the eyes of the fruit fly,
Drosophila melanogaster, and (b) human urine.
, . 31 *9 eIn case (a), biopterin was isolated along with two
other closely related pteridines by means of chromatography«
In case (b), blopterln was again isolated by careful
chromatographyp and was characterised as 2-amino=4-hydroiy-6=
(1*,2•-dihydroxypropyl)-pteridine (V)o
OHOH OH
HH
There are no substantiated reports in the literature 
dealing with the biosynthesis of this pteridine, and this 
problem will be dealt with in the theoretical section of 
this thesis.
BIOSYNTHESIS OP RIBOFLAVIN
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Recent views on the biosynthesis of riboflavin (I;
R « B«ribityl) suggest that it is also formed from purines 
through an intermediate 4D5-diamlnopyrimidine derivative 
(XXII; R « D-ribityl)o This hypothesis, which was first
OH Q W
ïz
M M OH
ISpostulated by MacLaren, has bean confirmed by many workers,
and thoir results are summarised bolow@
84Results obtained by Plaut, on the incorporation of
radioactively labelled compounds into riboflavin using Ashbya
36 *56goasypii, were similar to those obtained by Buchanan et al. 
on the incorporation of the same labelled compounds into 
uric acid (XXVII).
16
XXVII
1 4Thus," C-formate enters position 2 of riboflavin, and
14 14positions 2 and 8 of uric acid, C-carbon dioxide or CHg. CC^B
enters position 4”of riboflavin, and position 6 of uric acid,
and the carbon atoms of glycine enter positions 9& and 4& of
riboflavin, and positions 4 and 5 of uric acid» The nitrogen 
of glycine enters position 7 of uric acid, and although no 
degradation has as yet been worked out that will give the 
contribution to the individual nitrogen atoms in riboflavin, 
nitrogens 9 and 10 contain thirty times the amount of label 
carried by nitrogens 1 and Goodwin and his group supported 
these incorporation studies by showing that serine stimulated
37 #56flavinogenesis, and that before its incorporation, it was
sotransformed to formate and glycine. Adenine could dilute out
36 3 9the incorporation of serine. Further support cane from Klungsyr,
who demonstrated the incorporation of labelled formate into the
2 position of riboflavin*
Important evidence for the conversion of purines into
40 #41riboflavin came from the work of McNutt, who, working with
adenine and the mould Eremothecium ashbyii, showed that in the
transformation, carbon atom 8 of the purine was **lost**. He
14 40confirmed this result with 8» C adenine and with randomly
41labelled adenine. From his results, he came to the conclusion 
that the contribution of the purine to riboflavin was an intact 
pyrimidine ring.
The vital intermediate in the transformation of purines 
is probably 5-amino-4-D=ribitylaminouracil (XXIIi R ■ D-ribityl), 
even although this compound has never been isolated or detected 
in vivo. This failure to detect such an important precursor 
is, however, not surprising, as it rapidly undergoes self-condensa* 
tion» This is discussed further in the theoretical section of 
this thesis. The formation of the ribitylaminopyrimidino from
^  X
<:ti
HO CHj
OH OH
purine nucleoside ribosylamino-pyrimidine ribitylaminopyrimidine
the corresponding rlhosylaminopyrimldine which would he
expected to bo the primary product obtained from the ring-
opening of a purine nuoleosldéf is also discussed in the
theoretical section*
42Goodwin has established that the purine precursors
of riboflavin fall into the following order of decreasing
effectiveness; guanine, xanthine, adenine, hypoxanthine,
and uric acid. This order is of interest in view of the
ring-opening reaction of guanosine, which will be discussed
later in this thesis.
The other portion of the riboflavin nucleus which hae
still to be accounted for, is the benzene ring, and it is hero,
that the focus of present controversy is situated. Fortunately,
48 #44some elegan^ work with tracer compounds has given a clear
picture on which to base subsequent work,
48îirch was first to suggest the now generally accepted 
pattern for the formation of the benzene ring skeleton which sris©» 
from the head to head and head to tail linkages of four colocules 
of acetic acid, probably as biacetyl or acetoin, derived from 
four molecules of pyruvic acid,
48Plaut, using incorporation techniques, has been able to
14demonstrate the following scheme. The label from CC^E is
Co,H
} M t X h O \
pyruvic acid 
CO
I
acetaldehyde
CO
I
CO o Birch’s Picture
incorporated at positions 6 and 7t and positions 8a and 10a
14of the riboflavin mucleua» and the label from glucose [ 1- c]
14 14and glucose [6- C], which are metabolised to acetate CHgCO^Hy 
is incorporated in the methyl groups, and in positions 5 and 8*
44Goodwin also demonstrated that the label from acetoin,
14labelled with C in one of its methyl groups, is incorporated 
one half in the methyl groups of riboflavin, and the other half
in positions g and 8* ^
-------
/ Gtuco5c£i-
J £4“ **cj
The origin of the atoms forming the benzene portion of
riboflavin is established, but there is considerable uncertainty
as to how the benzene ring precursor presents itself to the
diaminopyrimidine•
46 »47Masuda was first to suggest that biacetyl or
acetoin condenses with the ribitylaminopyrimidine (XXII* R «
D-ribltyl) to give 2,8-dihydro=4-hydro%y-6D7-dimethyl=2-o%o=8-
d-ribitylpteridino (11$ R * D-rlbityl) which he called for
47convenience G-compound, He then postulates that G-oompound 
reacts with a further mole of biacetyl or acetoin to give 
riboflavin (l$ R • D-ribityl).
A -A
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Evidence for this route has gained support from tho
22 24*46fact that Masuda and others have been able to isolate
G-compound from both E.ashbyil and A.gossypil.
The strongest evidence that G-compound is a precursor
in the biosynthesis of riboflavin, oomes from its transformation
49 *80 *81 *52 47into riboflavin by various biological systems» Masuda
claims that G-compound reacts with biacetyl at 120=1)0* vitro
to give riboflavin, but this condensation could not be repeated 
89by Birch.
A critical study of the biological systems used in the
transformation of G-compound to riboflavin, suggests several
points which indicate that an alternative pathway for the
biosynthesis of the benzene ring of riboflavin may operate»
This second hypothesis is based on the chemical studies 
46*59by birch and Moye» Two moles of biacetyl can be self-.
48condensed to form an aldol of probable structure (XXVIll), 
which reacts as a hexane trione (XXIX) on condensation with 
either 4,5-diaminouracil (XXII* R « H) or 5-amino-4=methylamino 
uracil(XXUçR « Me) to give respectively the pteridines (XXX)
/ V 45 *59and (XXXI* R « Me) or their 7-isomers
1 I
y y w r  x x i l
Me
48 , -C/cllsation of the pteridine (XXX) was carried out 
by reflux in N-sodium hydroxide solution to give lumichrome
59 '(XXXII), while the cyclisation of the 8-methylpteridine was 
achieved in polyphosphoric acid giving lumiflavin (l| R > Me)
OH 
MeoHMe
Me OM
XXXI/ 54Recently, Wood and Cresswell have isolated a trimerlc
form of biacetyl, which appears to have structure (XXXIII).OH
C H j —  C  —  O v  > C 0 . H €I
c — Zf f l Z
55
/  o —Me MeThis trimer behaves in aqueous solution as a mixture ofMe
biacetyl and the dimeric aldol (XXVIII) or the related 
open-chain hexane trione (XXIX). Thus it reacts with
5=amino=4=D=ribitylaminouracil (XXIl; R « D=rlbltyl) to give 
a mixture of 298=dihydro=4=hydroxy=6,7-methyl-2=oxo~8=D- 
-ribitylpteridine (ll) and the pteridine (XXXI* R « D-ribityl) 
or its 7-isomero . The latter pteridine was cyclised readily 
to riboflavin with polyphosphoric acid. It then appears 
that the triraeric form of biacotyl could explain the formation, 
by micro-organisms, of riboflavin together with G-compound (ll)
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In previous sections of the thesis, hypotheses dealing 
with the biosynthesis of pteridines and flavins, were discussed 
In general, the initial step im such biosynthetic paths 
involved ring-opening ,of the imidazole ring of a purine or 
purine nucleoside. Evidence in the literature dealing with 
ring cleavage in purines and related heterocycles, will now 
be discussed.
56Benz imidazoles
This group of compounds consists of a benzene ring fused 
to an imidazole or l,)-diazole ring system, giving the nucleus 
(XXXIV)o It thus bears a formal similarity to the purine 
nucleus (XXXV).
Stepwise alkylation of benzimidazole gives first a 
mono-alkyl derivative (XXXVl) which on farther reaction with 
an alkyl halide, gives a l,)-dialkylated benzimidasoliuin 
salt (XXXVII) RI
Q N
Under the influence of warm alkali, 1,^-dialkyIbens- 
imidagolium salts undergo ring fission with the formation of 
a molecule of an N,N*-dialkyl-o-phenyl©nediamine (XXXVîîl) and
QGa molecule of formic acid. The transformation of the salt 
(XXXVll) into the “ammonium base®* (XXXIX) initiates the 
reaotiono The proximity of the highly electron-attracting 
quaternary nitrogen atoms renders the carbon atom at position 2 
of the 1,^-dialkylbenzimidazoliûm ion electron-deficient, and
<2
this carbon atom is consequently attacked by a hydroxyl ion 
with formation of the "carbinol base*' (XL). Father hydrolysis 
brings about fragmentation of the molecule with the formation 
of N,N'rdialkyl-o-phenylenediamine (XXXVIIl) and sodium 
formats*
R
R
e
'z
R R
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Application to a purine nucleoside of a similar sequence 
of reactions, is discussed in the Theoretical Section of this 
thesis.
Purine Nucleosides and Nucleotidea,
(a) g-p-D-Ribofuranoaylpurine (»Nebularlne ** )
07Nebularine, a purine riboside isolated from the
mushroom A^aricus nebularis has been shown to have structure
(XLI) by comparison with a synthetic specimen prepared by Brown 
seand v/eliky. Study of the chemistry of this compound by
se ..Brown and his co-workers revealed that it was extremely unstable 
to aqueous alkali. Three degradation products were obtained: ' 
one of these was positively identified as 4,5-diaminopyrimidine 
(XLII). On the basis of their spectra, various colour reactions, 
and their behaviour on paper chromatography, the other two 
products were tentatively identified as glycosides (XLIII*
R » D-ribofurano5yl or B-ribopyranosyl) derived from 4#5-diamino- 
pyrifflidine.
Hocri I
 ^ , XLI XLIIIoH oH —  — — —
(b) Guanine Nuclooeldea and Nuoleotldea.
eo
XLII
Lawley and Wallick investigated the alkylation of 
guanylic acid (XLIV) using dimethyl sulphate at pH7, and
c. ï
later Lawloy^^ reported a similar méthylation of deôxyguanylic 
acid (XLV). Lawley deduced from his spectroscopic studies 
of these reactions that méthylation had taken place in each 
case at nitrogen-7 of the guanine moiety to give the quaternary 
salts (XLVl) and (XLVII) respectively. In the case of the 
deoxyguanylic acid derivative (XLVII), hydrolysis of the 
sugar residue occurs under the conditions of the experiment to 
give 7-methyl guanine (XLVIIl). Acid hydrolysis of the 
quaternary salt, derived from guanylic acid similarly gave 
7-mathyl guanine (XLVIIl).
O C H 2.
©
(
M
A
where (p), in both cases, « Eg P% .
The former quaternary salt (XLVl)c however* underwent
a more fundamental change on treatment with dilute alkali and
60Lawley and Wallick deduced from spectrophotometrie measure^ 
ments that ring»opening of the purine ring had taken place 
to give a 4,5-diaminopyrimidine derivative (XLIX)«
HOCH
O ©  OH
1 H  N
H O  C H i
o ©  O H
xux
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These workers were not able to isolate and characterise
either the quaternary salt (XLVï) or the pyrimidine glycoside
(XLIX). A further study of this reaction will be reported in
the Theoretical Section of this thesis as it obviously has a
bearing on the hypotheses already outlined for the biosynthesis
of pteridines and riboflavino
60Lawley and Wallick also found that alkylation of 
deoxyribonucleic acid (D.N.A.) using a nitrogen mustard (di- 
(2~ohloro@thyl)methylamine) gave* after acid hydrolysis* a 
7-alkylguanine as the major product. This showed that only 
the guanine moiety of ths D.N.A. was susceptible to alkylation 
under these mild conditions and that the reaction proceeded as
described above for the isolated nucleotide (XIA^ ).
62Hems has shown that a similar ring-opening of 
guanosine and guanylic acid can be brought about by th© 
action of ionising radiation on aqueous solutions of the 
purines. The products of the reaction were again characterised 
only by their ultraviolet absorption spectra and by thoir 
behaviour on paper chromatograms. It seems probable* however* 
that ring-opening has taken place in the imidaaole ring to 
give pyrimidine glycosides (L).
)0
where R » D»rlbosyl or D-ribosylphosphate.
A secondary reaction involved cleavage of the sugar
moioty and formation of guanine itself. Similar results were 
83obtained by the action of high energy electrons on the intact 
D.N.A. molecule.
These reactions are very similar to those brought about 
by the action of alkylating agents and they may go some way 
to explaining the so-called ** radiomimetrie *'* effect of the 
biological alkylating agentSo
(c) Xanthosine.
64Hemo has also described the ring-opening of xanthosine 
when subjected to ionising radiation. He reported that 
xanthosine ring-opens in the same way as guanosine giving a 
4,5-diaminouracll derivative (LI| R - D-ribosyl).
n(d) Adenine and Rypoxanthine Nucleosides eind Nucleotides.
When the purine derivative has only one substituent in the 
pyrimidine ring as in the case of adenosine (LII), and inosine 
(LIII), alkylation appears to take place in this ring, and this 
is followed by ring-opening reactions which leave the imidazole 
ring intact. Such results will therefore be discussed only 
briefly.
When adenosine (LII| R * D-ribosyl) was heated with
methyl sulphate in N,N-dimethylformamide at 100», followed by
acid hydrolysis, four main compounds were isolated by chromato
66graphy of the reaction mixture. They were 1-methyl adenine
(LIV), ^-methyladonine (LV), a 1,^-dimethyladenin® quaternary
)2
salt (LVI) and 5-aminoimidazol9=4=N'-methylGarboxyamidine (LVIl)
Both acid and alkali cleaved the pyrimidine ring of the purine
derivative (LIV), but in the case of the alkaline ring-openingj,
fission of the 1-2 bond resulted in the rotation of bond -^6
and subsequent reforming of the pyrimidine ring to give a
6-methylaminopurine derivative (LVIII).
Adenylic acid, the 5*-phosphate of adenosine behaves
68similarly on méthylation»
Shaw has described the alkylation of inosine (LIII&
R » D-ribosyl) using benzyl bromide» The initial product is
n
N
tho 1-benzyl derivative (LIX, R « D-ribosyl) which on treatment 
with alkali undergoes the expected ring-opening to give the 
imidazole (LX% R - D-ribosyl) and finally compound (LXIs R * 
D-ribosyl)o
ac^  67An agWT latlon using p-toluene sulphonyl chloride gave
68
similar results»
It is. interesting to note that Pullmann, using quantum 
mechanics, has calculated the relative electronegativity of 
each nitrogen of the natural purines, guanine and adenineo His 
results agree with the chemical evidence that positions 7 &nd 1 
respectively of these purines, are the centres of most probable 
alectrophilic ettacko
AMADORI REARRANGEMENT
Th© Amadori rearrangement is the irreversible isomerisa* 
tion of an N-substituted aldosylamine to a 1-substituted amino- 
1-deoxy-2-ketose in an anhydrous medium by acid catalysiSo 
R - N - R' R - B = R*I ÎH C ----IH-C - OH!HO —  C—  HIH—  C — OHIHC -ICHgOH
CH.
0
I
HO -C
IHO -C
H i
CH.
R
OÏÏ
OH
KUlll)
Tho example above shows the conversion of the acid 
labile N-glycosidc (LXIl).into its stabler isomor (LXIII) in the 
D-glucos© series.
Amadori pioneered this rearrangement, but he did not 
realise that an aldose-ketoso change was taking placeo This
70was later determined by Kuhn and Weygand who showed that 
the rearrangement isomer could not be hydrolysed by aqueous 
acid into its sugar and amine components.
71Amadori heated an aromatic amine and D-glucose 
together in the dry state, to give a brown mass from which was 
isolated the l-srylamino-l®deoxy=>D-fructose. Later workers 
extended the scope of the reaction to all classes of amines 
and aldoseso The use of anhydrous solvents and catalytic amounts
73of weak acids greatly improved the quality and the quantity
7 4 076of the product. Hodge used compounds containing active
methylene groups as catalysts, but such •'’catalysts’* must b®
present in relatively larger proportion* The rearrangement
is always accompanied by decomposition of the sugar moioty
forming tars which tend to colour tho reaction mixture.
The unsubstituted l-amino-l-deoxy-D-fructose was
78synthesised by Fischer, and was called isoglucosamine, This 
compound is usually prepared as a salt, e*g,, an acetate, 
because the free base which is an a-aminoketose, solf-condensos
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to form a dihydropyrazine derivative.
One characteristic feature of the products of Amadori 
rearrangements, is that they will readily reduce Redox
77indicators, such as methylene blue and o-dinitrobenzehe in 
alkaline solution. They do so, because they can be regarded 
as ammono analogues of ©ne-diols, e,g.: -
R - N - R »  R - N - R *  R - N-R*I I 9CS_ CHg CHgI \ IHO - G------ — i G - 0 C - OHI I ISHO — C — H HO— C— H G —  OH
I j * I
The carbonyl group can be reduced in neutral or alkaline
media by Adam’s platinum catalyst, usually giving an epi&eric
mixture of 1-oubstituted amino<=l«ci©oxy-glycitolSo
Tho Amadori rearrangement is becoming increasingly
important in chemical synthesis, V/eygand has used it in a
synthesis of riboflavin* and it has also been used in the
78preparation of folic acid. It is now suspected that this 
rearrangement is involved in the non-enzymic browning of food 
and ripening of fruits, as both these systems seem to involve 
sugar-amine condensations»
The possible application of this rearrangement in the 
biosynthesis of pteridines and flavins will be discussed in the 
Theoretical Section of this thesis.
THEORETICAL PART Ias IS !E ss » S3 se a 9 BK s a s at S3 S3 s St SB 8
Chemical Studies of the Biosynthesis 
of Riboflavin and Related Pteridines
36
15Weygand*s 'hypothesis for the transformation of purines 
into pteridines has already been summarised in a previous section 
of this thesis. He suggested that one step in the sequence of 
reactions involves the conversion of a pyrimidine glycoside of 
the type (LXIV) into a pyrimidine (LXV) via an Amadori rearrang®= 
ment * The final stages of his reaction scheme then involved 
intramolecular cyclisation of (LXV) to give a dihydropteridin®«
It is
of the carbonyl group of pyrimidine (LXV) could give a D-ribityl 
side chain as found in riboflavin (l). As it has been suggested 
that riboflavin itself arises from purine precursorsp this 
series of changes may explain the transformation of the ribosyl 
group of the purine nucleoside to the ribityl group of riboflavin 
in the biosynthetic pathway, provided that the side-chain remains 
attached to the heterocyclic moiety throughout the sequence of 
reactions o
57
Experiments using randomly labelled guanosine led 
79McNutt and Forrest to suggest that the ribosyl group of 
guanosine was not incorporated into the riboflavin molecule, 
since the ribityl side-chain of the latter compound was shown 
to contain little radioactivity. Such experiments are not 
conclusive, however, since the ribosyl group of guanosine is, 
without doubt, in equilibrium with a much larger quantity of 
D-ribos© in the metabolic pool, and the radioactivity would 
thereby b® greatly dilutodo
The principal aim of this section ie to prepare a 
pyrimidine {LXV^  X % « OH) and to study its conversion tc 
riboflavin. The* most reasonable approach would sosia to involve 
tho condensation of 4=Ghloro-5™Kitrour&cii (JJ1TÏ; with 1-aaino- 
9oXy Q-0rythrop3ntu 1 os® (LXVIl)^ followed by reduction of th$ 
5“nitro groupo
I
CH^CO(CHOH)^CHgOH
   ;L'ÿyf LXV/f CH,J.O(CHOH)^ CH^ OH
The pyrimidine (LXVI) is readily available as the
G 4result of recent work in this department, but a search of the 
literature revealed that only one l-amino-l-deoxy-D-ketose was
38
known and that is the D-fructose derivative (LXIX) known as 
isoglucosamine”9 It was therefore decided to carry out initial 
experiments using this sugar amine and to synthesise the model 
substance (LXX) by the method outlined above»
Oti
CHj.Co(cHOH) ChÎ2.0 H. N
HM u H
Two main investigations were undertaken with this 
model substanceo
(aj Reduction of the carbonyl group in the side chain» Th® 
possibility of a stereospecific reduction was given particular 
r.ttontioï?o Subséquent réduction of the ^«nitro group and 
condensation with an o-benzoquiaone derivative then gave a Cg» 
analogue of riboflavin»
(b) Reduction of the 5-nitro group and intramolecular 
condensation gave e dihydropteridine whoso properties proved to 
be very interesting»
f?.
RJ
L X X  I
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80 ,2p4«6-Trihydroxypyrimidine (LXXI, » Rg « Rg •» OHp
81♦‘barbituric acid* ), was converted to its trichloro derivative 
(liXXIf R^  = Rg - Rg = Cl). Alkaline hydrolysis of this 
trichloropyrimidine gave 4«»chloro«2p6°dihydroxypyrimidin®
(LXXIi R^  « Rg - OHj> Rg « Cl, ”4-chlorouraGil® ). This one-s
conversion was recommended by Langley, and is superior to the . 
two-step literature method* Nitration of 4-chlorouraoil using 
fuming nitric acid with concentrated sulphuric acid readily gave 
4=chlorC"2p6-dihydrozy-5-nitropyrimidin@ (LXVI)p which was 
extremely reactive, and which had no definite m,po Its purity 
was estimated routinely by means of its ultraviolet absorption 
spectrum, or mor®accurately, by reacting it with excess ethanol- 
amine and collecting and weighing the 2,6-dihydroxy-4“2♦-hydroxy-
64 ,ethylamino-5-nitropyrimidine (LXXII^ R « Cj^oCHgOIi) which 
rsoultedo
LXXII
The other component, l-afflino-l^deoxy-D-fruotoee (LXIX# 
♦♦isoglucosamine” ), was prepared by a modification of the
78literature method. Glucosazone was made from D-glucoss by
40
treating irith phenylhydrasine in an acetate buffer at 90*•
This material was hydrogenated while suspended in an acetic 
GCid-water-ethanol solvent$, under four atmosj^heres of hydrogen 
and using a palladium--barium sulphate c&talysto The disappear® 
anc© of the yellow osazone indicated the end-point of the reduction 
Isoglucoearciii© (LXIX) was isolated from the reaction mixture as its 
acetate6 Tï’eatmsnt of this acetate with the calculated amount 
of sodium athoxide, gave the fro© base 9 isoglucosamine» which 
was immediately condensed with half the molar proportion of 
pyrimidine (LXVI) added as an ethanolic solution*
oK oH
OH NN’ o M
LXXLXIX
l-[2* p6*-Dlhydroxy-5*-nitro^4*~pyrimldinylamino]-l-deoxy- 
D^fruotose (LXX) was isolated as hydroscopic white powder and 
T/as characterised by preparation of its oxime*
Reduction of the carbonyl group of pyrimidine (LXX) by 
sodium borohydride was carried out overnight in 0*1 N-sodium 
hydroxide solution,, After destruction of the excess borohydride 
with formic acid * the reaction mixture was adsorbed on an anion 
exchange resin at pHlO and the products wero eluted using
41
ammonium format© buffer at various pH values= Buffer at pK4 
eluted the major product which on isolation proved to be 2*6- 
dihydroxy“5“î^ltro-4«D«*8orbitylaiainopyrimidin9 (LXXII* R « D=> 
QOrbityl)o Proof of the stereochemistry of this product ie 
adduced below*
OH
M O
OH
Reduction of the ^-nitro group in (LXXII* R «« D-sorbityl) 
was achieved by reduction with sodium dithionite in 0*IN- 
odium hydroxide solutiono ?his chemical reduction proceeds 
through the corresponding 5*hitrosopyriffiidine (LXXIÎI* R « 
sorbityl) which has an intense red colour» giving finally the 
colourless $ ««amino compound (XXII* R » D«eorbityl ) *
oH
k
The pH of the resulting solution was adjusted to 5» an
63ethanolic solution of the dimer of $o4=dimethyl-o-benBOquinon®
42
(liXXîV) ivae added immediately and the orange mixture was
warmed for ten minuteso On G00lh%g6,7=dlmethyl-9-D-8orbityli8O'
84 , -, .ûlloxazine (I; R « D-sorbityl, **sorboflavin** )g separated.
OH
Addition of the o»b©nsoquinonc must not bs delayed 
otherwise the 5«amlno=4=D^Gorbitylamlnouracll (XXZI* R « D- 
sorbityi) undergoes an oxidation solf«aondonsation to givo &
pyrimidoptoridin® (LXXV^ R « D-eorbity 1 j <, This compound ccn.
- 86, . also b© prepared by addition of alloxan (XJCXVl) to the
pyrimidine (XXIÎ§ R « D-sorbityl). Thus, alloxan was added to a
similar solution of this pyrimidine at pE5« The mixture
bèîcam© purple p probably du© to the 5=oxo group of alloxan
condensing with the 5=&Qiao group of the pyrimidinoo Subsequent
reflux for 2 hr<> in N-hydroohloric acid solution gave a yellow
solution of 2,10-dihydro-d,6,6-trihydroxy=2-oxo-10-D-8orbityl-
pyrimido[5*4~g]pteridine (LXXV; R - D-sorbityl) which separated
on cooling. Pyrimidopteridinee (LXXV) of this type have a
strong light blue fluorescence in aqueous solutions of high
dilution.
45
HO À  h /
R
r m / L
The pyrimidopteridine {LXXV# R » D^sorbityl) was 
dissolved in water and treated with excess sodium periodate 
solution and left overnight. 2plO“Dihydro»4 »6,8“trihydroxy-2«=> 
-oxo-lO-formylmethylpyrimido[jpteridine (L X X V R  « GDg .CHO) 
separated and was reduced in alkaline solution with sodium boro- 
hydride to give 2pl0-dihydro=49&p8-trihydroxy-2=oxo=10~2*- 
hydroxyethylpyrimido[ 5i>4°g]pt©ridina ( LXXV $ R « CHgoCHgOH). This 
material was identical in infrared and ultraviolet spectra and on 
paper chromatography in various solvents with an authentic sample 
made by condensation of alloxan (LXXVI) with 2*6-dihydroxy=4-2*-
G 4  ,hydroxyethylamino-5=nitropyrimidine (LXXIIe R « CHg.CHg OH) 
which had previously been reduced with sodium dithionite in 
alkaline solution.
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From the foregoing series of reactions, it is obvious 
that & polyhydrosyalkyl side-chain must have been present in 
the pyrimidopteridine (LXXV; R = D-sorbityl) aad must have been 
of structure (LXXVII) as it is oxidised by periodateI
-  CHg (C K O H jjC H g  OH —  CHg oCIlO  —^  CHg oCHg OE
(LXXVII) (LXXVIII) (LXXÎX)
to the aldehyde (LXXVIII) which is then reduced to a 2 * «îiydroxy- 
ethyl radical (lXXIX) with sodium borohydride. Since the side 
chain (LXXVII) arose from the side chain (LJCXX) of the original 
pyrimidine (LXX)j
—  CHgCOfCHOajsCHgOE
(LXXX)
only the stereochemistry at Cg in the side chain (LXXVII) of 
the reduction product is in doubt «
Theoretically reduction of the carbonyl group of a 
D-fructoee derivative should give an equimolar mixture of the
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two epimersp in this caesp a D-glucose (D«sorbose) derivative and 
a D-mannose derivative. Renee reduction of the pyrimidine 
(LXX) with sodium borohydride should give an epimeric mixture 
of a D«‘3orbitylaminopyrimidin0 (LXXXI) and a D-mannitylaraino- 
pyrimidine (LXXXIl).
L a .H N "  O H
! I,
Orliy H* C.H
t ~ I
CO N - c -
AN
I H O  — C
I IH “■ C  ’-OH H ~  C
H E  L X X V I I
In the reduction of compounds of this type, an
equimolar epimeric mixture is seldom obtained as the pyrimidine
ring and the remainder of the asymmetrical sugar moiety exert
steric effects: because of this only one epiraer is often
73produced. Weygand made use of this stereospecific. reduction 
in his synthesis of riboflavin from D-arabinose which is 
described later.
To determine the percentage of each epimer formed in 
the reduction of l-[2*,6*=dihydroxy-5*-nitro-4*-pyrimidinylamlno] 
l-deoxy-D-fructose (LXX), the unambiguous synthesis of each 
isomer was carried out.
D-glucose Series.
86D-glucose oxime was reduced over Adams platinum 
catalyst under hydrogen to give D-sorbitylamine (LXXXIIIi 
R » D-sorbityl) which was reacted with 4-chlorO“2ç6-dihydroxy«5' 
nitropyrimidine (LXVI). A crude solution of resulting 2*6= 
dihydroxy-5“nitro-4“D-sorbitylaminopyrimidine (LXXII? R » 
Borbityl) v/as purified on a column of an anion-exchange resin 
(Amberlite CoG.400-formate form). Ammonium formate buffer at 
pH4 eluted the pure pyrimidine.
oH
1 a  " ' —^ N
R
L X V I  LXXX II
LXX II
Reduction of the nitropyrimidine (LXXII# R = D-sorbityl) 
with sodium dithionite and condensation with alloxan gave the 
D-8orbitylpyrimido[5p4-g]pteridine (hXXVf, R « D-sorbityl) which 
could also be prepared by oxidative self-condensation of the
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5-aiiiinopyriiaidine (XXIIj R « D-sorbityl). Similar condensation 
of the latter compound with the dimer of $94=dlmethyl-o-benzo- 
quinon© gave the D-sorbitylfiavin (1* R « D-sorbityl) which had
0 4bean reported by Karrer. Acétylation of this flavin in pyridine-
84acetic acid gave a penta-acetat©. Karrer did notp however^ fully 
characterise either of these compounds* and the appropriate details 
are recorded in the experimental section.
CH ÔH fsU rxU
I
XXÏÏ A .
D-Hannose Series,
89D-Mannose oxime was reduced in a similar manner as 
in the section above. The same reactions were carried out using 
the resulting D-mannitylamine (LXXXÏII5 R ® D-mannityl) to give 
the D-marnitylflavin (l| R « D-mannityl) and the p y r i m i d o [ ] 
ptoridine (LXXV; R « D-mannityl). The penta-acetato of the 
D-mannitylflavin was not prepared.
The following table summarises the physical constants of 
the products in the two series and compares them with the products 
formed from the reduced l-[ 2 * * 6 ®-dihydroxy-5 ’ "^ i^tro-/? * —pyrimldinyl-
48
aminoj~l-d©oxy-D«fruetoS8 (LXX).
Pyrimidines Pyrimido- Flavins Flavin Acetate
______ Pteridines ________ _____ __
ia.p~ mTpl ra.p. - mTp. 1
Reduced '
D-fructos© 225" +15* > $00" +61" 274* -45* 2)8
D-glucose 225 +17*5 >500 +60 275 -45 2)8
D-mannose 247 - 2.5 >)00 +1? 205 +61
«
The reduced pyrimidine (LXXII^ R « D-sorbityl) was found to 
be identical in all respects* melting point* specific rotation* 
ultraviolet spectra and paper chromatography in various solvents* 
with 2p6-dihydroxy-5-nitro-4«D-sorbitylaminopyrimidine (LXXII^
R « D-sorbityl), From the table* it is obvious that the pyrimido- 
pteridines and flavins derived from these pyrimidines are also, 
identical. Their spectra and values were also identical.
Sodium borohydride in alkaline solution has therefore 
reduced l-[2* *6*-dihydroxy-5®-nitro-4“-D-pyrimidinylamino]»l- 
dooxy-D-fructose (LXX) steroospecifically to 2,6-dihydro%y-5-nitro-
4-D-sorbitylaminopyî*imidine (LXXÎÎÿ R « D-sorbityl).
This ^  vitro reduction may well indicate that the 
biosynthetic pathway to riboflavin from purines* does involve a 
pyrimidine glycoside which undergoes an Amadori rearrangement* 
followed by a storeospecific reduction. It is interesting to not© 
that the D-glucose derivative is formed in this reaction. If
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D-crythro-pentulose* the Cg analogue of fructose* is used* then, 
by analogy, we might expoct formation of the D-rlbose derivative.
The above model experiments having proved successful, 
attention was now turned to the synthesis of pyrimidine (LXVg 
X a Y « OH) which would result from Amadori rearrangement of a 
pyrimidine glycoside of type (LXIV^ X =» Y « OH). This necessitated 
the preparation of 1-amino-l-deoxy-D-erythro-pentulosc (LXVII),
Wo 0^,
% I
C H g
CO.(cHOH)^ CHgOH
c
OH O n  Reduction of the oaasone of D-arabinoee was carried out
7Susing the same conditions as for D-glucose* but no solid could 
be isolated On testing a little of the syrup, however* with
77o^-dinitrobenzeno in alkali* a positive test for an Amadori 
cne-diol compound was obtained. Treatment of the crude base with 
4«chloro-2,6-diliydroxy-5-nitropyrimidine (LXVI) was not attempted 
as the reaction mixture contained aniline and ammonia which would 
alcd react to give a complex mixture of 5-nitropyrimidines. An 
alternative approach to the sugar amine was therefore attempted.
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Recently Micheel and Hagemann have prepared N-bensyl 
D-xylooamine and have shown that this compound undergoes an 
Amadori rearrangement when treated with an equimolar amount of 
anhydrous oxalic acid in dry isopropanol.
D-arabinose (LXXXIV) and benzylamine were therefore 
condensed in ethanol to give N-benzyl-D-arablnosylamine (LXXXV) 
which was rearranged in dry dioxan using a molar quantity of 
anhydrous oxalic acid to give l-bcngylamino°l-deoxy-D°erythro- 
pentulose oxalate (LKXXVl) in good yield. Catalytic débenzylation 
in ethanol using a palladium charcoal catalyst gave i-amino-1- 
d(i?oxy-D-ery thr0°»p®ntu 1 osQ oxalate ( LXXXVII) . This compound gave
77a deep purple colour with o-dinitrobensene in alkali.
OR NB.CHgPh (C02H)2 pNHoCHç oPh N% .(COgH)^
CH
IHO - G - E
IH - C - OH
H - C
CE,i
C « 0 !
H - G - OH
9^.IC “ 0
iH - C - OE
H OH H - C OE
CHjOH CHg OH CHg OH CHg OH
(LXXXIV) (LXXXV) (LXXXVI) (LXXXVIl)
The oxalate residue was removed from the l-amino-l-deoxy« 
D^ >ery thro-pentulose (LXVII) by treatment with sodium ethoxido. 
The free base was immediately condensed with 4-chloro-2*6- 
dihydroxy-5-.nitropyrimidine (LXVI) giving l-[2• * 6 *-dihydroxy-5 ®- 
nitro-4 »-pyrimidinylamino]-le.deoxy-D-orythrQ-pcntuIoae (LXVIII).
OH
4 I '  > 1  J.{[ J CH,C0/£HôH)g_CH^0U
ON
^ O H oH
CHgCo(^MOH)^CKgOW.
L%v( LXVII T xv ï ïT
Sodium borohydride in alkaline solution reduced the 
carbonyl group as bofors to give 296=dihydro%y=5=nitro»4- 
D^ribltylaminopyrimidine (LXXIIg R « D«ribityl).
O H
Sodium dithionite reduction of the nltro group and 
subsequent condensation at pH6 with alloxan gave 2{,lO-dihydro*>4D^pQ“ 
triliydro2cy-2«oxo-lO“D«ribitylpyrimido[59 4-*s3ptQridine (LXXV5 
R D^rlbityl). Similar treatment of the f>-arainopyrimidin©
/ X OB(1XXI§ H a* D-ribityl) with the dimer of 3î>4-dimethyl°£“benzoquinono 
gavo  6p7-dimethyl«9’-R-ribityl-isoalloxasine (l& R = D-ribitylp 
"Riboflavin** )o
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It has been assumed that the epimer obtained from the 
reduction of pyrimidine (LXVII) was 2p6-dihydroxy-5=nitro-4= 
=D-ribltylpyrlmidlne (LXXII» R « D-rlbltyl), Proof that this 
reduction was stereospecific* was again determined by synthesising 
both ©pimors unambiguouslyo
LXXXV/li L.XXXIX
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By analogy with the above model experiments, it was 
expected that reduction of pyrimidine (LXVIII) with sodium 
borohydride, would give an epimeric mixture of a D-ribityl- 
aminopyrimidine (LXXXVIII) and a D-arabitylaminopyrimidine 
(LXXXIX).
To dotermine the percentage of each epimer formed in the 
reduction, the unambiguous synthesis of each isomer was carried 
out as beforeo
D-Arabinose Series.
89D-Arabinose oxime was reduced as in tha D-glucose series» 
Condensation of the resulting D-arabitylamine' with 4*chloro-=*5<=- 
nitrouracil (LXVI) gave pyrimidine (LXXXIX)» Reduction of the 
5-nitro group as before and condensation with alloxan^ gave 10-D= 
arabity.l«2, iO-dihydro«45 6p8-*trihydroxy-2-oxopyrimido[ 5p4-g]pt@ridine 
(LXXVj R = D-arabityl)» D-Arabitylflavin (I5 R » D-arabityl) is
90well characterised in the literature.
j
;
OH
L AI
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D-Ribose Series
The physical constante of 2,6-dihydroxy-5-nitro-4- 
D-ribitylpyrimidine (LXXXVIIl)f 2,10-dihydro-4,6,8-trihydroxy-2= 
-o%o-10*D-ribltylpyrlmldo[5p4~g]pteridine (LXXV^ R « D-ribityl) and 
riboflavin (l| R « D-ribityl) have all been given by Creeewell and
54Wood*
The following table summarises the physical constants of 
the products in the two series and compares them with those of the 
products formed from the reduced l-[2*,6*-dihydroxy-$*-nitro=4'= 
pyrlmldinylaminoj-l-deojcy-D-erythro-pentulose (LXVIII)
Series Pyrimidines Pyrimidopteridines Flavins
ra.p. H d m o p o m.po
Reduced D-erythrp pentulose 202® ♦5® > 500® =33* 288® .116»
D-riboso 204* +4o5“ > 500® -26* 29Z^ =■115*
D-arabinose 185* -17o5’ > 500® -76* 505" 67*
The reduced pyrimidine (LXXXVIII) and its derivatives were 
found to be identical in all respects, melting point, specific 
rotation, ultraviolet and infrared spectra and paper chromatography 
in various solvents with 2,6-dihydroxy-5-nitro-4-D-ribitylamino= 
pyrimidine (LXXII^ R « D-ribityl) and its derivatives*
Sodium borohydride in alkaline solution has therefore 
r«duced l-[2•,6 «-dihydroxy-5'-nitro-4•-pyrimidinylamino]-l-d*oxy-D-
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»€j:ÿjbhrqpentulose 8tereospecifically to 2\6-dihydroxy-5-nitro=4= 
D-ribitylaminopyrimidinô.
85Condensation of 5»4“dimetbyl-£.-bQnsoquinono (LXXIV)
with 5"&#lKO™4™D-ribitylaminouracil (XXIIi H » D-rlbityl)
constitutes a new synthesis of riboflavin (l# R « D-ribityl)* This
work has been published recently In a joint paper* The method can
be extended to the preparation of all 6,7-dimethylflavins (I) by
condensation with the appropriate 5”a.minouracil derivative (XXIl)
OM
Me
LXXIV
A
The uracil derivative may be prepared in two ways.
(a) Direct condensation of a sugar amine (LXXXIII) and 4-chloro- 
-^-nitrouracil (LXVI) gave a 5-nltrouracil derivative (LXXII) which 
coula be reduced to the 5-aminouracil derivative (XXII).
(b) Condensation of a l-amino-l-deozy»ketose (XC) and 4*chloro« 
b-nitrouracll (LXVI) gave a 1-pyrimidinylamino-l-deozy-ketose 
derivative (XCI). It has been shown above that the carbonyl 
group in these compounds can be reduced stereospecifically to a
5-nitrouraoil derivative (LXXII)$ followed by reduction of the 
nitro group to give a 5-aminouraoil derivative (XXII).
$6
Cri,ôH
Method (a) allows the preparation of all flavins of the 
6»7*dimethyl type where as method (b) is limited to exactly half 
that numbero This, of course, assumes that stereospecific 
reduction of the carbonyl group as described above, will always 
be possible g
Perhaps the most elegant of previous riboflavin syntheses
75is that by V/eygand which involved the use of the less expensive
D-arabinoseo This sugar was condensed with 5?4-xylidine (XCII)
in the presence of small amounts of acid to give the D«arabinosid®
(XCIII) which underwent an Amadori rearrangement upon heating to
75® to form the D-erythropentulose derivative (XCIV)o Catalytic
hydrogenation in alkaline medium converted the ketoso to 4ç5-dimethyl<
-l-D-ribitylaminobenzane (XCV)« The second amino group was
98introduced by coupling with a diazonium salt to form an azo-dyo 
(XCVl), which on reduction, either catalytically or chemically.
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0Sgave the diamine derivative (XCVII). Condensation with 
alloxan in the presence of boric acid, gave riboflavin (I; 
R - D-ribityl).
NH.
JCCIIÎ
>
^ 1 ^ 1  ■ I I
o
CH%_I ,CHiOH. (CHoH)3 fiH. (cH0H)3
The weakness of this method resides in the oxygen 
sensitivity of the required o-phenylenediamine derivative (XCVIl) 
which is 80 pronounced that this intermediate is never isolated,, 
Another notable recent synthesis due to Crcsswell and
64v.ood, was outlined in the historical section * This involved a
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novel preparation of 5-amino=4-D-ribitylaminouraGil (XXII;
R *3 D-ribityl). Condensation with the aldol of biacetyl gave 
a pteridine derivative which underwent intramolecular condensation 
on warming in acid to give riboflavin* The weakness of this 
method resides in the oxygen-sensitivity of the required diamino™ 
uracil derivative and in the use of D-ribooe which is expensive* 
This latest synthesis of riboflavin combines the best 
points of both those earlier synthesis *
(1) D-Arabinose is used in preference to the more expensive 
D-ribo00o
(2) Condensation between 4-chloro-5-nitrouracil and 1-anino-l- 
deoxy-D-erythropentulose is very efficient as in Creeswell's 
synthesis.
This method also makes use of 5?>4~dimethyl-o-benzoquino2iQ 
which condenses smoothly with the disminouracil derivative at pH6p
I BThe next step in Weygand’s hypothesis for the 
Jiosynthosis of xanthopterin involved intramolecular condensation 
of the rearranged 5-aminopyrimidine derivative (LXV) to give a 
pteridine derivative (XCVIII) which could then oxidise to a
6-hydroxypteridine (XCIX) with loss of the polyhydroxyalkyl 
side-chain?
X CH3.0H
I
(CHOH
"Z
If, however, oxidation of pteridine (XCVIII) removes 
water instead from the ^=6 bond, then an unambiguous synthesis 
of biopterin-type compounds (C) from pyrimidine glycosides is 
possible*
3
Biopb^(^tn
This may well be the biosynthetic route to these pteridines 
It appears, therefore, that all the well-known natural pteridine 
groups - flavins, xanthopterin and its analogues, and biopterin 
type compounds could arise from a common intermediate, pyrimidine 
(liXV) which is produced by Amadori rearrangement of a pyrimidine 
glycoside which in its turn, can be obtained by degradation of a 
purine nucleoside.
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Investigation of these proposed reactions was now
attempted using l-[2 »,6*-dihydroxy=5*-nitro-4'-pyrimidinylamino]-
1-deoxy-D-fructose (LXX). Raney nickel reduction gave the
dihydropteridine (Cl) which proved unstable in air,but was
characterised as its sodium salt. 2p4-Dihydroxy-7,8=dihydro-6-
fp-arabo-tetrahydroxybutyl1pteridine (CI) gave 2,4»6-trihydroxy-
pteridine (CIl) on aerial oxidation in alkaline solution. This
material was identical with an authentic sample of 2,496=
94trihydroxypteridine in ultraviolet and infrared spectra and on 
paper chromatography in various solvents. No trace of the 
polyhydroxyalkylpteridine could be detected but other unidentified 
pteridines were formed in trace quantities.
? I , I \
^ (21 C T T
L X y  During one experiment the sodium salt of 7,8=dihydro-
2,4,6-trihydroxypteridine (GUI) separated from the reaction 
mixture. Further standing in alkaline solution converted this 
salt to the fully aromatic 2,4,6=trihydroxypteridine (CII).
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Oxidation of 2*4=dlhydroxy-7e8-dihydro-6-rD=arabo- 
tetrahydroxybutylJpteridine (Cl) to give 2>496-trihydroxy-’ 
pteridine (CIl) could also be carried out by cold alkaline 
potassium permanganate*
Although these results were rather disappointing so 
far as the synthesis of polyhydroxyalkylpteridines was concerned
15this series of reactions supports Y/eygand*s hypothesis and 
provides a reasonable biosynthetic route to xanthopterinp since 
2,4e6-trihydroxypteridine (CII) is the 2-hydroxy analogue of 
xanthopterin (VIIl).
CH
HO
OH
OH
H
CII VIII
This problem is at present being investigated in this 
Department> but will not be considered further in this Thesiso 
An alternative approach to 6«polyhydroxyalkylpteridines 
was suggested by experiments in the literature which lead to the 
synthesis af quinoxalines* Weygand and Bergmann have 
synthesised a 2«polyhydroxyalkylquinoxaline derivative (CIV) 
directly from an £-phenylenediamine derivative (CV) without 
involving a 1,2-dihydroquinoxaline.
CV
fiHi
NH
CHj^ .CO. (chOh) jCHjOH
CVI
NH
CH^.C.(CHOH)^CH^Ori
M.
CV..I
   \  M H\
c v n
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The hydrazone (CVI) rearranged in acetic acid solution 
to give finally (CVIII) which Underwent intramolecular condensation 
to give a quinoxaline derivative (CIV) directly.
As the dihydropteridine (Cl) obtained from the intra* 
molecular condensation of l-[2*,6*-dihydrbxy=5*-nitro=4^pyrimidinyl 
aminoJ-l-deoxy-D-fruetose (LXX) has been shown to be unstable, 
a reaction scheme of the above type, suggested itself. This 
method would by-pass oxidation of the labile diliydropteridino 
(Cl) and should give the biopterin<=type compound in one stepo
It is interesting to note that rearrangement of the 
hydrazone derivative as described above, is a very elegant 
method for oxidation of the side-chain before intramolecular 
condensation and hence oxidation of the bicyclic product is not 
required.
To test this rearrangement of the side-chain in pyrimidine- 
pteridine transformations, it was decided to use a simple model. 
This involved preparation of 4“acetonylamino-2,6-dihydroxy-5=> 
nitropyrimidine (LXXIIf R = CHgoCOoCHg) which would lead to 
2,4-dihydroxy-6-methylpteridine (CIX).
OHH M
OH OH
IR c T x
Condensation of 4-chloro-5=nitrouracll (LXVI) with 
96aminoacetone was unsatisfactory and so the condensation was
97carried out using the semicarbazone of aminoacetone (OX), 
giving 4-ac®tonylamino-5-nitrouracil semicarbazone (CXl)o This 
was hydrolysed to the parent pyrimidine (LXXII^ R = CHg.CO.CHg) 
with N-hydrochloric acid at Hydrolysis at reflux tempera,
ture gave a different product, 4,5-dihydro=7-hydroxy=)=methyl= 
8-nitro=5-oxoimidazo[l,2~c]pyrimidine (CXII) whose occurrence 
will be discussed later in this section.
OH
IR
OH
I
CI — >
i 
CH,
L X X M
Mo.1
OHHM
CM,. C .  C H ^IIM. NH COHH
OH
MO.
C X H
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Since two products were obtained from acid hydrolysis, 
it was necessary to determine which one was the free methyl 
ketone.
The product from hydrolysis at 57* coujd be converted 
to the second product by refluxing in acid solution for a 
short time. An iodoform reaction on the product from hydrolysis 
at 57“ gave 2,6^dihydroxy=5=nitro=4-pyrimidinylaminoacetlc acid 
(LXXIIi R = CHgCOgH; which on sodium borohydride reduction in 
alkaline solution gave 2,6-dihydroxy-5~nitro=4-2*-hydroxyethyl= 
aminopyrimidine (LXXII; R - CHg.CHgOH).
This latter material was identical in all respects with 
an authentic sample prepared by condensation between ethanolamine 
and 4-Ghloro=5=Hitfowracil. It seems therefore that the product 
from hydrolysis at 57* is 4-acetonyl&mino™5-nitrouraGil (LXXII^
R -  CHg .CO,CHg )o
4-Acetonylamino-5=nitrouracil formed a hydrazone (CXIIl) 
in the usual way. Reduction of the 5~nitro group of this 
compound with hydrogen over a Raney nickel catalyst and subsequent 
reflux with 2N-acetic acid gave 2,4-dihydroxy-6-methylpteridino 
(CIX), identical with the material made by oxidation of the 
corresponding 7t6-dihydropteridine (CXIV). This was prepared 
directly from 4-acetonylamino-5-nitrouracll (LXXII* R - CHg,CO.C%) 
by reduction of the nitro group and subsequent condensation»
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The ultra-violet spectrum of 2*4-dihydroxy-6-methyl-
.pteridine (CIX) v/as virtually identical with those of 2^4^
»6 . , 90dihydroxypteridine (CXV) and its 6p7*=dimethyl derivative
(CXVl) which were prepared by standard methods.
OH cH
OH
CXV
M
H N
ICH^» C  • Crij
oH
CXVl IIH. MHCOHHj^
Reduction of the ^-nitro group of 4-acetonylamino=5=
nitrouracil semicarbazone (CXI) with hydrogen over a Raney nicks 
catalyst and subsequent reflux with 2N-acetic acid gave 7^8=
dihydrO“2,4-dihydrosy=’6=methylpteridine (CXIV)* identical with 
material made from 4=acetonylamino=5=nitrouracil.
It is interesting to note that reduction and subsequent 
reflux of the semicarbazone gave the dihydropteridine and not the 
fully aromatic substanceo There cannot be any rearrangement 
within the semlcarbazide group such as that described for the 
hydrazono residue and so acid removes the group intact* The 
resulting 4~acetonylamino=5=aminouracil then condenses lntra= 
molecularly to give the 7e8=dlhydropt@rldine derivative (CXIV)*
The other product from acid hydrolysis of the semi­
carbazone has been identified as 4p 5=dihydro“7=*hydroxy»5=methyl« 
8=nitro=5=o%oimidazo[%,2=cjpyrimidine (CXIl)o
C H ~  C
This is presumably formed by condensation between the 
carbonyl group of the acctonylaraino side chain which can react 
in its enolic form (CXVII) and the pyrimidine ring nitrogen atom 
5 to give a pyrimidine=lmidazole fused ring-system© The 
ultraviolet spectrum of pyrimidine (CXII) was ,20 mu higher than
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a pyrimidine of typo (LXXII) at both pHl and 1). An increase
in conjugation between the pyrimidine and imidazole rings
probably accounts for this difference® The bicyclic system
may therefore exist in the tautomeric form (a ).
OH
OH r  4-
M e
Chemical evidence for this structure (CXII A) came from 
the fact that when the 6-nitro group was reduced to an 8-amino 
groupo compound (CXIl) could not undergo an oxidative self­
condensation or condense with alloxan in acid medium. This 
indicated'that nitrogen atom 1 was tertiary®
These model experiments have shown that this approach 
to fully aromatic pteridines via hydrazone derivatives is 
reasonable9 and synthesis of a 6-polyhydroxyalkylpteridine by 
this method was now attempted.
The hydrazone (CXVIIl) of l-[2*,6*-dihydroxy=5*-nitro 
-4 »«pyrimidinylaminoj-l-deoxy-D-fructose was prepared in the 
usual way. Reduction of the 5*-nitro group and subsequent 
reflux with 2N-acetic acid gave a reaction mixture containing 
three compounds® Examination of paper chromatograms showed the 
main spot to be a fluorescent yellowj the others were present
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only in trace amounts• An orange solid was obtained from the 
reaction mixture» This was very soluble in water and had an 
ultraviolet spectrum which was completely new but bore a slight 
resemblance to that of the flavins »
The structure of this product has not been fully 
elucidatedc However, if the polyhydroxyalkylpteridine (CXIX) 
had been formed then the terminal hydroxy group of the sid@=chain 
could condense with nitrogen atom 5 of the pteridine ring to give 
a tricyclic ring system with the skeleton (CXX)o
oH
! , V(CHOHj^CHiOH L
CXVÏÏI
The feasibility of this type of cyclisation has been 
iOOdemonstrated by Lister and by the following experimento
On warming 2,6=dihydroxy=4«2*-hydroxyethylamino=5~nitro- 
pyrimidine (LXXIIi R « CEgoCHgOH) in N-hydrochloric acid solution* 
2,),4,5=tetrahydro=7=hydroxy=8=nitro-5=oxoimidazo[lp2-@jpyrimidino 
(CXXI) was formed.
OH
!
Q
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This is another case of intramolecular condensation 
between a ring nitrogen atom and an oxygen function of a side^chain. 
As in the case of the imidazopyrimidine (CXIl), the product was a 
much more stable compound with a higher melting point than that of 
the parent pyrimidine (LXXII* R - CHg CHg OH)o The ultraviolet 
spectrum of the imidazopyrimidine (CXXl) was however* similar to 
that of its parento This was expected since this condensation 
has produced a fully reduced imidazole ring*
An attempt to bring about this type of condensation in the 
case of a 2«arninopyrimidine was unsuccessfulo Thus* acid reflux 
of 2-amino=6=hydroxy=4"2*=hydroxyethylamlno=5=nitropyrimidin@
(CXXII? R « CHgCEgOH) in N-hydrochloric acid only gave starting 
materialo DM
%
%
This is possibly due to the fact that 2-aminopyrimidines 
101are known to exist in the •amino* form where there is no proton gn
the adjacent ring nitrogen, whereas 2-hydroxypyrimidines exist
102predominantly in the 2-oxo form in which the ring nitrogen 
does carry & proton;-
I
H
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Since the imidazole ring of 2,3,4^5»tetrahydro«7"hydroxy=> 
0-nitrO“5”O^o-l*ûidazo[lj)2-€]pyrimidine (CXXI) is fully reduced9 the 
nitrogen atom at position 1 is secondary* and so oxidative self= 
condensation and condensation with alloxan should occur on 
reduction of the 8-nitro group* The products of these reactions 
were different although both were bright orange crystalline solids 
The former has not been identified* The product from the alloxan 
condensation however* appears to have structure (CXXIII) analogous 
to those discussed earlier in this thesis* since it exhibits 
ultraviolet absorption characteristics of a pyrimido[5»4“gjptoridin® 
of type (LXXY)o Compound (CXXIIl) was called 1*2,6*10*11*12= 
hexahydro»4>6«=dihydroxy=2 *6-dioxoimidazo[l*2%2*2-ij]pyrimido[5*4=gj 
pteridine.
HO
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Table of Ultraviolet Aboorption Spectra
R = CHg GHz OH 228
216
(2 3 .0 0 0 ), (17,900), 324 (3331
[13,400)[11,500) pHlpH13
R * CHg CO (CHOK)j CHa OH 228
220
(1 8 ,3 0 0 ), (12,000), 32313371[11,100)[10,900) pHlpH13
R =5 IA»sorbityl 228
2 É0 (1 8 ,5 0 0 ).(13,700), 32213361 [11,000)[14,300) pillp_H13
R 3* H^maiîîilty 1 228
220
(19,000), (13,900). 3241 340 ([11,100) ■ [14,500) pHlpH13
R = CHg CO(CKOH) 3 CHg OH 228
219
323
335
pHl
pH13
R « D—ribityl 228
217
(20,700), (13,900), 323 13361[11,200),14,000) pKlpH13
R m D^arabltyl 228
220
(19,000), (12,100), 3223351
[10,900)[13,400) pHl pill 3
R = CHaC(M©) w N.NHCONKa 228
224
(1 8 ,6 0 0 ),(18,500), 31413331[12,800)9.700)
pHl
pH13
R = CHg COM© 228
220
(2 1 ,4 0 0 ), (11,500). 31413321[14,300)(12,700) pHlpnrj
R m CHgC(Me)mN.NHg 228
220
(17.800),(13.800), 3161336
[11,600)[12,400) pHlpH13
R = CHgC(tNOH) (CH0 H )3 CHgOH 228
220
(17,800),(26,500), 319 (3371[12,400)[15,000) pHlpH13
R m CHgC( sN.NHg ) (CHOH), CHgOH 228
224
(1 4 ,3 0 0 ).(14,500), 31513361[11.300)[13.300) pHlpH13
(CXIl) 224(10,600), 26813601[5.500)Ç ,11,600) pHl
238(12,000), 394 (9,700) pH13
(cxxi) 228
221
(24,000), (1 5 ,8 0 0 ). 32213341
[13.500)[16,400) pHlpK13
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Pyrlmldo [5  9 pteridines
(l x x v )
R « CHa.CHaOH 228(20,kOO), 278(9300), 422(20,800) pHl
2 3 1(2 9 ,100), 272(13,100), 4 3 6 (3 1 ,4 0 0) pII13
R « IVeorbltyl 224(25,800), 280(9500), 422(l8,400) pHl230(32,100), 272(16,000), 438(25,800) pH13
R ■ D-manaityl 230(22,100), 280(l0,800), 422(22,300) pill231(26,500), 272(11,600), 433(27,600) pH13
R « CHaCHO 221(23,800), 276(l5,200),404(20,300) pHl232(21,300), 272(10,000), 436(23,400) pH13
R * D-rlbltyl 229(25,200), 280(9800), 422(22,200) pHl230(23,400), 272(9900), 433(28,000) pH13
R . D-arabityl 230(26,600), 280(ll,900),421(27,100) pHl231(27,000), 272(11,900), 434(30,400) pH13
(CXXIII) 226(19,700), 278(9500), 418(19,300) pHl232(28,000), 274(12,000), 436(32,200) pHl3
Self=>Cojideneatlon 224 267 418of CXXI 232 274 436
IfloallosazAnes (l)
E « D-eorbityl 222(27,500),266(29,000),374(lO,000),444(ll,400) pHl
222(25,000),270(28,100),356(9900), 449(9700) pH13
R . Dcinannltyl 223(34,300),266(37,000),374(l2,600),444(l3 ,500) pHl
222(23,000),270(26,700),356(8900), 445(8500) pH13
R = »-ribltyl 223(35,500),267(35,500)*376(10,700),445(11,500) pHl222(26,600),270(31,700),356(10,600),447(10,600) pHl3
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Other Pteridln»ffl 
(CII)
(cxx)
(cxv)
(cxvi)
(cxiv)
2 2 2 (9 8 0 0),
234(12,500)
205(21,200)
218(11,700)
204(20,000)216(8800),
203(19,500)216(11.100)
2 2 8(1 1 ,2 0 0)226(23,000)
258(8700), .274(10,300),
.230(17,600),,254(16,500),
,228(19,400),252(14,200),
,324(10,800),,240(18,000),
,267(15,400),,276(13,000),
3 6 4 (4700) 
394 (6100)
331(10,500)370(6100)
323(13,000) 
3 6 6 (4700)
3 4 6 (9 0 0 0)
350(4500) 318(6500)
pHl
pH13
pHl
pH13
pHl
pH13
pillpH13
pHl
pH13
Cyclisatien of (CXVIII) 204, 236, 281, 402 219, 270, 410. pHlpH13
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2.AB6=Trihydrùxypyrimidine("barbituric acid») =  Ethyl
malonate (80 g«) and urea (30 go) in absolute ethanol (230 ml*) were
added to sodium ethozide [sodium (llo5 g*) in absolute ethanol
(250 mlo )] and the mixture was rofluxed for 7 hr* in an oil bath at
100-110®* Hot water (3OO ml* at 50®) was then added followed by
12N=hydrochloric acid solution (47 ml*). After stirring, the
solution was filtered and left to stand overnight at 0®-* The
crystalline product was collected, washed with cold water (50 ml*)
and oven-driod at 100-110® for 2 hr* to give off-white crystals
(50 go, 79%)» mopo 240® (decompo) [lit*, m*p* 240®]*
812,4,6-Trichloropyrimidine. - 2,4*6=Trihydroxypyrimidin@
(50 go) was added portionwise over 10 min* to a mixture of diethyl- 
aniline (95 mlo) and phosphoryl chloride (I56 ml*), after which the 
whole was refluxed for 5 min*, cooled, and poured on ice (000 go)* 
The mixture was extracted with ether (750 ml*) and the ether 
extract was dried over anhydrous sodium sulphate* The ether was 
removed by evaporation in vacuo and the oily residue was subjected 
to fractional distillation at reduced pressure, the fraction of 
bop* 110® being collected to give the trichloropyrimidine (48 g,
66%) as a clear viscous dil with extreme vesicant properties 
4-Chloro-2,6-dihydroxypyrlmidine (4-chIoroura.çil^ J
2,4,6-Trichloropyrimidine (48 g*) was refluxed for 16 hro in a 
solution of sodium hydroxide (41*8 go) in water (420 mlo)o On
o
as
76
cooling the sodium salt of 4-chloro-2,6-dihydroxypyrimidin« 
separated, and this was converted to the’ free pyrimidine by 
addition of 12-N hydrochloric acid solution (50 ml*)* The 
product was collected, washed with water, dried over silica gel, 
to give the pyrimidine as a white powder (35o2 go). Crystallisa­
tion from water gave needles (32*0 g*, 84%), mop* 300*.
644-Chloro-2,6-dihydroxy-5-nltropyrimidine* - 4-Chloro»2,6- 
dihydroxypyrimidine (5 go) was dissolved gradually in concentrated 
sulphuric acid (6 ml*, 36n) at 0*. After cooling the mixture in 
a carbon dioxide-acetone bath, fuming nitric acid (dpi*5, ml*) 
was added portlonwise* The mixture was kept below 0® until solution 
was complete and then left at room temperature for 30 min« until 
solid precipitated, after which it was treated with ice (20 g*)*
The white product was collected, washed with ico-water (2 x 20 ml«)n 
ether (2 x 20 ml*) and dried in vacuo over phosphorus pentoxide* 
Yield 3o5 g., 55%, m.p* 222® [lit*^^ 220-222®].
Glucosazoneo - D-Clucose (20 go), sodium acetate tri­
hydrate (60 go), and a saturated solution (50 mlo) of sodium 
metabisulphite were added to a solution of phenylhydraziner I
hydrochloride (40 go) in water ,(400 mlo). The solution was 
filtered to remove tarry material cuid heated on a steam-b&th 
until precipitation of the yellow osazone was completeo The 
solid was collected, washed with warm ethanol, until the washings
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wera coloürleaa and then with ether and dried to give the product 
(50 g., 75?S)in.p. 2X0*.
76 / \Isoglaoosanine Acetate* - Glucosazotie (20 go) was made into
a paste with a mixture of glacial acetic acid (100 mlb)« ethanol
& 06(50 mlo) and water (20 mlo) A palladium*barium sulphate catalyst 
(5 go) was added to the mixture which was shaken overnight under 
hydrogen at 3^5 atmo The catalyst was removed and the filtrate 
was concentrated in vacuo to an orange oil. Ethanol (100 mlo) 
was added and the mixture was left overnight at 0*. A white 
solid separated, and this was removed and washed with ethanol 
(2 X 20 mlo)o Crystallisation from 90% ethanol gave colourless 
needles (a g., 60^ ) m.p. 1)7° [ lit., 1)7"].
l-[2**6*-Dihydroxy-5*-nitro-4 *-pyrimidinylamino |-l-deoxy- 
D-fructoseo - An ethanolic solution (50 mlo) of sodium (0*47 go,
2 eqo) was added to suspension of ieoglucosamine acetate (5 g«,
2 eqo) in ethanol (30 mlo) and the mixture was left at room 
temperature for 1 hr* An ethanolic solution (30 ml*) of 4-ohloro-
2,6-dihydroxy-3-nitropyrimidine (2 g*, 1 eq.) was then added with 
stirring when a yellow solid precipitated almost immediatelyo 
After 30 min* the solid (2 g», 35%) was collected, quickly washed 
with ethanol (50 ml*) and ether(2 x 30 mlo)# and dried over
phosphorus pentoxide. This compound proved to be very hygroscopic;
and was characterised as its oxime, see below.
78
l-[2•,6•-DihydrQxy-5*-nltfo-4 *-pyrimld inylamino1-1-deoxy- 
D-fruotoae oxime* - An ethanolic solution (10 ml*) of sodium 
(23 mge) was added to a'suspension of hydroxylamine hydrochloride 
(70 mg.) in ethanol (10 mlo) and the mixture was left for 30 mino
An aqueous solution (10 ml.) of l-[2*^6*-dihydroxy-3*-nitro-4'-
pyrimidinylamino]-l-deoxy-D-friictoso (334 mgo) was then added and 
the mixture was refluxed for 1 hr* After leaving the solution 
overnight at 0®, a solid (3OO mg.) separated* Concentration of 
the mother liquors yielded a further 50 mg* Recrystallieation from 
water gave the oxime as micro-needles (250 mg*, 70%) Qo p* 291* 
(Founds C,34o7l H,4o6| N,20ol« ^ gNg0^  requires C,34o4» H,4o3#
N,20oC%) [a]^  - 49o8 (c,0o20 in 0o05N-Ra0H)o
86 . .D-Olucoae Oxime. - Hydroxylamine hydrochloride (15o4 go)
was dissolved in hot water (23 ml*). To this was added an equally 
warm solution of sodium (4o6 go) in ethanol (60 ml.). On cooling*
sodium chloride was filtered off and was washed with ethanol
(2 X 20 nil.). Anhydrous D-glucose (36 go) was dissolved in the 
filtrate and the solution was kept at 35*40* overnight* After 
7 days in the refrigerator micro-needles (20 g. 31%), had 
separated, m.p. 135*C [lito*% 137^].
D-Sorbitylamina. - P-Gluoose oxime (4«0 g.) in water 
(130 ml.) was shaken with platinum oxide (0.5 g.) under hydrogen 
until the theoretical volume (920 ml.) had been absorbed. The 
catalyst was removed, and the resulting solution of P-sorbitylamine
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was used directly*
2*6-Dihydroxy-5-nltro-4-D-sorbitylamlnopyrimidine* -
(a) To the above solution of crude D-sorbitylamine was added 4*
chloro-2,6-dihydro%y-5-nitropyrimldlne (1*6 go) in ethanol (I50
ml*)o The mixture was heated on a steam bath for I5 min*, then
brought to pH5 with 2N-hydrochloric acid solution and chilled
104overnight. A little 4-aQino-2,6-dihydroxy-5-nitropyrimidin@ 
separated and was removed. The pH of the filtrate was adjusted 
to 10 with ammonium formate buffer* and the solution run on to a 
column of an anion exchange rosin (Aoberlite CG 4OO* formate form) 
which had previously been prepared by washing the resin with 
ammonium formate buffer (0*1M with respect to formic acid) at 
pHlOo The column was washed thoroughly with ammonium format® 
buffer at pHlO and then with buffer of pH? (0*1M with respect to 
formic acid)& a bright yellow pyrimidine was eluted which showed 
ultraviolet absorption maxima at 218 and 334 mu at pH13 but is as 
yet unidentified.
Elution with buffer of pH4 (0*1M with respect to ammonia) 
eluted a second pyrimidine in a narrow band. Concentration 
in vacuo of the eluate gave 2,6-dihydroxy-5-nitro-4-D-8orbitylaminO' 
pyrimidine as a white solid (1*6 g** 55%)» Recrystallisation 
from water gave needles* m.p* 224-225* (Pound: C,34o3$ H*4o9* 
N*16.0. Og.Hg0 requires C*3d*0$ H,5ol| R,15*8%), +
17*5* (c,0*20 in 0o05N-Na0H)o
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(b) l-[2•,6»-Dihydroxy-5*-nitro-4*-pyrimidinylamino]-l-deoxy- 
D-fructose (1*2 go) was dissolved in Oo2N-sodium hydroxide solution 
and an aqueous solution (10 ml*) of sodium borohydrido (o*15 go) 
was added with stirring* After the initial reaction was complets, 
the yellow solution was stirred for a further 2 hr* at room 
temperature* After neutralisation with formic acid which 
destroyed the excess borohydride* the pH of the solution was 
adjusted to 9 with ammonium hydroxide solution and the solution 
was chromatographed as above* The nitro-pyrimidine was eluted 
from the column in pH range 4o5*4eO and these fractions were 
bulked and concentrated to 20 ml* A white powder (800 mg«, 66%) 
was precipitated by addition of ethanol (60 ml*)* Crystallisation 
from water yielded the pyrimidine as micro-needles, mop* 225*,
[aJjj + 15* (c,0ol8 in 0*05 R-NaOH)*
Samples from methods (a) and (b) wore identical in all 
respectso
6.7-Dimethyl-i-D-sorbitylisoalloxazine* - 2,6-Dihydroxy-
-5"nitro-4-D-sorbitylaminopyrimidine (4OO mg*) was dissolved in
OolR-sodium hydroxide solution (25 mlo) and the nitro group was
reduced using solid sodium dithionite* When the reduction was
complete, the pH of the solution was adjusted to 5 by 2N-hydrochlor«
io acid solution* An alcoholic solution (10 mlo) of the dimer of
833,4-dimethyl-£-benzoquinono (320 mg*) was added* The mixture
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was heated for JO min. at 90® and was finally made strongly acid 
by the addition of more 2N-hydrochloric acid solutiono On 
cooling, pure 6.7-dimethyl-9-D-8orbityll8oallo%azlne separated as 
orange needles (11) mg.,2)%), m.p. 275* [lit.,272*] (Found* C,52ol; 
Hf5o5l R,l)o4. 8 Hgg Oy o Oo 5Bg 0 requires C,52ol* H,5.6| N,13o5%)*
[a]p - - 4 5* (o,0.18 in O.OJN-NaOH) (litV, - 47*7 *)*
Samples of this flavin. Identical in all respects, were 
obtained using starting material prepared by either method (a) 
or (b) above.
6,7°Dimethyl-9-D-8orbitylisoalloxagine penta-acetatet> - 
6,7=Dimethyl-9-D-8orbityli8oalloxazine (100 mg.) was heated in
pyridine (40 mlo) with acetic anhydride (40 mlo) for 5 mino The
mixture was cooled and diluted with chloroform (60 mlo). The 
organic layer was shaken with 2N-hydrochloric acid solution until 
acidic to Congo Red indicator paper and then washed with water 
(4 X 50 mlo). The chloroform was removed in vacuo leaving an 
orange residue which crystallised from aqueous ethanol as needlee, 
m.p. 2je* (lit., 2)7 ") (found, 0 ,54.5» H.5.9. Cje%2 Oi, .
CgHg.OH require. 0 ,54.4» H,5.S^).
2,lO-Dibydro-4 ,6,8-trihydroxy-2-oxo-lO-D-aorbitylpyrimido 
f5#4-glpterldine. - (a) 2,6-Dihydroxy-5-Ditro-4-D-sorbitylaalno- 
pyrimidine (400 mg.) was dissolved in O.lR-eodium hydroxide 
solution and the nitro group was reduced in the usual way Using 
s61id sodium dithionite. When the reduction was complete, the
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pH was adjusted to Jo5 by addition of 2N-hydrochloric acid 
solutiorio Alloxaii (190 mg®, I d  eq. ) was added immediately, the 
mixture was refluxed for 2 hr. and left overnighto 4 yellow 
solid separated (520 mg., 65%)* Recrystallieation from 
N-hydrochloric acid solution gave the pyrimidopteridine as bright 
yellow needlee, m * P o 525* (Founds 0,57*6$ H,4*4$ N,18.4*
6^ %  * 0 requires O,57o5$ H»4o5( N,'18o7%), [®]j) ^ 61* (c,0o26
in 0„05N*Na0H),
Samples of this pyrimidopteridin®, identical in all 
respects, were obtained using starting material prepared by either 
method (a) or (b) above
(b) 2,6-Dihydroxy-5-nitro-4“D»Borbitylaminopyrimidine (2J0 mgo) 
was reduced in alkaline solution as abovo. On adjustment of th© 
solution pH to 2, the reaction mixture was reflux©d for 2 hro 
giving a yellow solution from which separated the pyrimidoptoridinc 
as a yellow solid (100 mg., 65%)9 identical with that prepared 
in (a) aboveo
lO-FormyImethy1-2,lO-dihydro-4,6,8-trihydroxy=2-oxo- 
pyrimidof5o4-#]pteridine. - 2plO-Dihydro-4,6,8-trihydroxy-2- 
oxq~lO-D«8orbitylpyrimido[5,4-g]pteridin8 (180 mg.) was dissolved 
in water (50 mlo) and an aqueous solution (10 mlo) of anhydrous 
sodium periodate (650 mgo-6 eq.) was added. Yellow crystals 
separated during 2 days at room temperature. Recrystallisation 
from water gave the pyrimidopterid ine as bright yellow plates.
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(Founds C,J8*9$ H#2.)$ N#27*3* o ^ ^  requires
C,38o9| 11,2.6$ H,27o3%)-
542,6-Dlhydroxy-4$2•-hydroxysthylamino-5-nitropyrimidine.
-  \
(a) To an ethanolic solution (20 ml.) of ethanolamine (2)0 mg.,
2 eq.) was added an ethanolic solution (jO ml.) of 4-chloro-2,6- 
dihydroxy-J-nitropyrlmidine (400 mg., 1 eq.). The mixture was 
heated on the steam bath for 10 min., then cooled. The white 
solid which separated was recrystallised from aqueous ethanol as 
needles (4OO mgo,95%) m.p. 219* [lit., 217-219*].
(b) 4-Âcetonylamino-2,6-dihydroxy-3-nitropyrlmidine (200 mg.) wore 
dissolved in water (5 ml.) and an iodine-potassium iodide solution 
(1 rale) (iodine (125 g*) and potassium iodide (250 go) per litre) 
was added. N-Sodium hydroxide was added till the reaction mixture 
became yellow. On warming to 60®, iodoform separated leaving a 
solution of the sodium salt of 2,6-dihydroxy-5-aitro-4-pyrimidinyl 
amino acetic acid which was reduced overnight using sodium boro- 
hydride (70 mg.). Neutralisation with 2N-hydroohloric acid and 
concentration iji vacuo of the reaction mixture gave a white solid 
(100 mg., 55%)* Reorystallisation from aqueous ethanol gave 
needles» m.po 219*»
This material was identical in all respects with the 
material prepared by method (a).
2,lO-Dihydro-4,6,8-trihydroxy-lO.2•-hydroxyethyl-2-oxo 
pyrlmldoÇ3,4-g3pt.rtdln.. - (a) St6-l)lhydroxy>4«2'-hydroxyethyl~ 
araino-5-nitropyrimidine (216 mg.) was dissolved in O.lN-sodium
hydroxide solution and the nitro group was reduced using solid 
sodium dithionite. When the reduction was complete, the pH was 
adjusted to 3*5 by the addition of 2N-hydrochloric acid solution. 
Alloxan (182 mg. 1.1 eq.) was added immediately, the mixture was 
refluxed for 2 hr. and left overnight. A yellow solid separated 
(200 mgo 36%) and was recrystallised from water to give the pjncjlm= 
l^Pptej^dine as bright yellow needles, mop. ) 325*# (Found* C,36c>0t 
H,3o7l N,26.5. CjjjHgNgO^j.HgO requires C,38.7l H,3o3l N»27d%)o 
(b) lO-FormyImethy 1-2,lO-dihydro-4,6,8-trihydroxy-2-oxopyrimldo 
[5,4~gjpteridine (60 mgo) was dissolved in Oo2N-sodium hydroxide 
solution (10 mlo) ana an aqueous solution (5 ml.) of sodium 
borohydride (I3 mg.) was added. The mixture was left overnight, 
ahd then 2N-hydrochloric aoid solution was added to give pH3* A 
yellow solid separated and was reozystallised from water, to give 
the pyrlmidopterldine (36 mg»,39%) yellow needles, m.po)3^5**
This compound proved identical in infrared, ultraviolet 
spectra and on paper chromatography in various solvents to a sample 
prepared by method (a).
D-Mannose Oximet Hydroxylamine hydrochloride (7*1 g.) was 
dissolved in hot water (3«3 q1.). To this was added an equally 
warm solution of sodium (2o3 g«) in ethanol (40 mlo). On 
cooling, sodium chloride was removed and washed with ethanol 
(2 X 10 mlo). B-Hannose (10 go) in water (7 ml*)was added to the 
filtrate and the mixture was heated at 70* for 90 mino On
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cooling the oxime separated. Reorystallisation from water gave
97needles (10 g. 90%) m.p. 182* [lit.,184*].
D-Mannitylamine. - D-Mannose oxime (2*5 g.) In water 
(150 mlo) was shaken with hydrogen and platinum oxide (0*5 go) 
until the theoretical volume (580 mlo) had been absorbedo The 
catalyst was removed, and the resulting solution of D-mannitylamlne 
was used direotlyo
2.6-Dihydroxy-5=nitro-4-D-mannitylaainopyrimidine » -
To the above solution of crude D-mannitylamine was added 4-ohloro- 
2|0-dihydroxy-5-nitropyrimidine (lo25 g.) in ethanol (lOC ml.).
On adjustment to pH 5» the solution was left at room temperature 
for 24 hr. 4-Amlno-2,6-dihydroxy-5-nitropyrimidine (100 mg.) 
separated and was removed. The pH of the filtrate was raioed to 
10 and put on to an anion exchange resin column (CG 400$ formate 
form) similarly prepared as for the D-sorbitylaminopyrimilineo 
Buffer eluted 2,6-dihydroxy-5°nitro-4-D-mannitylaciinopyrimidine 
at pU4 and concentration of the eluate gave a white solid. 
Reorystallisation from water gave needles, m.p. 247* (Founds 
C,33ol% H,5o4| H,l5o3o Cj^Hj^H^Op .lo5HjO requires C,33oO$
[a]j, - 2.5* («,0.22 in 0,05N-Ba0fl;.
6.7-Dimethyl-9-D-mannitylia3alloxa«lneo - 2,6-Dihydroxy 
T4=D~mennitylamino-5-nitropyrimidine (4ÔO mg.) was dissolved in 
OelN-sodium hydroxide solution (25 ml.) and was reduced using
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solid sodium dithionite. When the reduction was complete, the 
pH of the solution was adjusted to 5 with 2N-hydrochloric acid 
solution. An ethanolic solution (10 ml.) of the dimer of
S33,4=dimethyl~o-benzoquinono (320 mg.) was added. The mixture 
was boated for 30 min. at 90* and finally made strongly aoid by 
the addition of more 2N-hydrochloric acid solution. On cooling,
6.7-dimethyl~9-D-mannityli8oalloxBZine separated (240 mg.^49%) as 
orange needles, m.po 283* (Found* 0,32.4# H,3»2# N,13.3*
3HgO requires 0,32.1# 8,3*6# 3,13*5%), + 61*
(c,0@18 in 0o03N»Na0H). This material was quite distinct from 
the analogous D-sorbity1 compound.
2,lO-Dihydro-4.6.6-1rihydroxy-lO-D-mannity1-2-ox opyrimido 
f5,4-gjpteridine. - 2,6-Dihydroxy-5-nitro-6-D-mannitylamino
pyrimidine (400 mg.) was dissolved in OolN-sodium hydroxide eolu» 
tion and the nitro group was reduced using solid sodium dithionite 
Vi’hen the reduction was complete, the pH was adjusted to 3*5 by 
the addition of 2N-hydrochlorio aoid solution. Alloxan (190 mg.
- 1.1 eq.) was immediately added, the mixture refluxed for 2 hr. 
and left overnight. A yellow solid separated (JOO mg. 61%). 
Reorystallisation from N-hydrochloric acid solution gave the 
pyrlmidopterldine as bright yellow needles. m.p. )> 323*
(Found* C,36.4i 8,4.6# R,17*8. .58^0 requires 0,36.0#
H,4.8| [aJjj + 17* (o.O.JJ in 0.05’-HaOH).
This material was also quite distinct from the analogues
D-sorbityl compoundo
N-Benayl-D-arabinosylamineo - D-Arabinose (3 go) and
benzylamine (4 go) were refluxed together in ethanol (30 mlo) for
13 mino The mixture was left at 0 * for 2 days. A white solid
(3 g<«i 60%) separated. This was collected by filtration and
washed with ethanol ( ) 0  ml. ) and then with ether ( ) 0  mlo).
Reorystallisation from ethanol gave the glycosylamine as fine
colourless needles, m.p. 116* [a]^ - 4*) (Found* 0,60.3# H,6o9#
»#5o7. requires 0,60.3# H,7ol# W,3o9%)o
i-Benzylamino-l-deoxy-D-erythropentulose Oxalate. -
The above glyoosylamine (3 g.) was dissolved in dry dioxan (70 ml.)
and cooled, ana a cold solution of anhydrous oxalic acid (1.8 g o )
in dioxan (30 ml.) was added. A colourless oil formed which was
probably the glyoosylamine hemioxalatso On gentle heating to
40-30* this oil slowly dissolved and a jelly precipitated causing
the whole reaction to become solid. Water (10 mlo) was added
ahd the jelly dissolved on gentle boating. On standing overnight,
a white czystalline solid separated which was identified as benzyl-
1 osamine hemi—oxalate by m.po 180*, mixed m.p. and infrared 
spectrum. Dioxan was removed from the filtrate in vacuo leaving 
a yellow solid. Reorystallisation from ethanol (30 ml.) gave the
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oxalate (j go, 40%) as needles, m.po 145® 4- 5o2® (Found#
CgJOoB# H,5c8# R,4o2. C12B17HO4" (002^)2 requires 0,51. J# H,5o8#
N,4o2%)o
This compound gave a purple colouration with o-dinitro-
77benzene in alkaline solution.
l~Aj?lno-l°deoxy-D-crythropentulose Oxalate (*Isoribosaminc 
Oxalate»). - l-Benzylamino-l-deoxy-D-erythropentulose oxalate 
(2o8 go) was dissolved in ethanol (50 mlo) and added to a suspension 
of previously reduced palladium-charcoal catalyst (1 g.) in 
ethanol (20 mlo). The mixture was hydrogenated until 1 mole of 
hydrogen had been absorbed (220 mlo). The catalyst was removed and 
the filtrate was taken to a colourless gum ^  vacuo. Crystallisa­
tion of this gum from mothanol-ethanol gave the oxalate (1 g.,
50%) as needles, m.p. 70® (Found? C,34o75$ H,5o9^ ' N,5o9o
NOg requires 0,54.9# iI,6o2| N,5o8%).
This compound gave a purple colouration with o-dinitrobensen© 
in alkaline solution.
l-[2',6 »-Dihydroxy-5 *-nitro=4'«pyrimidinylamino1-1°deoxy= 
-D-erythropentulgse. - l-Benzylamino-l-deoxy°D°erythropentuloee 
oxalate (5*0 g. ) was dissolved in ethanol-v/ater (50 ml,, 4il) and 
reduced as above. After removal of the catalyst, an ethanolic 
solution (40 mlo) of'sodium (0.4 g*, 2 eq.) was added to the 
filtrate, which was refiltered to remove sodium oxalate. An 
ethanolic solution (jO ml.) of 4=chloro=5=nitrouracil (ôJO mg.-O.J eq,)
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was added and the reaction mixture warmed for 13 min. Ethanol 
was removed in vacuo and the pH of -the aqueoue residue was raised 
to 10 and run on to an anion exchange resin (Amberllte CG 400« 
formate form) which had been prepared in the usual way. Elution 
with buffer of pH4 gave a pyrimidine as a narrow band. Concentra­
tion ^  vacuo of the eluate gave the required 5-nitropyrimidine ae 
a jelly which was used directly in the experiment belowt The 
amount of pyrimidine (600 mg.) present was determined by ultraviolet
intensity. This compound gave a deep red colouration with
77o-dinitrobenzene in alkaline solution.
2,6~Dihydro%y-3~nitro=4-D=ribitylaminoDyrimidlne. «=*
Crude 1-12*,6'-dihydroxy-3'-nltro-4'=pyrimidlnylamino]-l=deoxy=D= 
erythropentulone (600 mg.) as a jelly from the above experiment 
was dissolved using 23-sodium hydroxide (2 ml.). An aqueous 
solution (3 mlo) of sodium borohydrido (0.08 g.) was added, and the 
mixture stirred for 13 mino and left for 2 hr. After neutralisa­
tion with formic acid which destroyed the excess borohydride, the 
pH of the solution was raised to 10 with ammonium hydroxide. The 
solution wap chromatographed as abqve. Buffer of pR4 eluted a 
pyrimidine whose fractions were bulked and concentrated to 10 ml. 
in vaouo. Addition of ethanol (30 ml.) precipitated the nitro- 
pyrimidine ()00 mgo) as a white solid, m.p. 202* [lit.^^ 204^ ,
+ 5* ( |0o21 in 0o03H-Ha0H). . This material was identical
in all respects to an authentic samole.
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2,10-Dlhydro=4«6o8=trlhydroxy-2-oxo~10-D=ribltyl&yrlmido
[5e4"glpteridlno. - 2,6-Dîhydro%y~5-nitro-4-D=ribltyl&minô=
pyrimidine (4OO mgo) was dissolved in OolR-sodium hydroxide solution
and the nitro group was reduced using solid sodium dithioniteo
When the reduction was complete, the pH was adjusted to 5«5 by the
addition of 2N-hydrochlorio aoid solution. Alloxan (I90 mg. -
loi eqo) was immediately added, the mixture refluxed for 2 hr. and
left overnighto A yellow solid separated (300 mg. 65%)o
Reorystallisation from R-hydroohloric acid solution gave the
_ 106pyrimidopteridine as bright yellow needles, mop. >  325* [lito #
525*1 [®ljj - 35* (c,0o20 in Oo05R-NaOH)o. This material was 
Identical in all respects with an authentic sample.
6»7~Dimethyl-9-D-ribityll8oalloxazine (»Riboflavin *). - 
Z,6-Dihydroxy-5-nltro=4-ribitylaminopyrimidine (200 mg.) was 
dissolved in OolN-sodium hydroxide (20 mlo) and was reduced using 
solid sodium dithionitoo When the reduction was complete, the 
pH of the solution was adjusted to 5 with 2N-hydroohlorio acid 
solution* An ethanolic solution (10 mlo) of the dimer of 3o4=*
83dimethyl-o-bensoquinone (ISO mg*) was added* The mixture was
heated for 30 min* at 90* and finally made strongly acid by
addition of more 2N-hydrochloric acid solution* On cooling,
6,7-dirrethyl'-9*D*ribitylisoalloxazino separated (90 mg*, 1)9 %) as
86orange needle*, [lit* gpZ» j [aJ j j ,0*53 in 0.10
N-NaOH). This material was identical in all respects with ah
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authentic eample»
6 0D^Arabinoae Oxlme. - Sodium ethoxide (1.16 g. of sodium 
in 25 ml. of ethanol) was added to a solution of dry hydroxylamine 
hydrochloride (jo6 g.) in water (10 ml.) and the mixture was 
allowed to stand overnight. After removal, by filtration, of 
sodium chloride, the filtrate was heated to 70* and D»arabinos@
(5 go) was added. The mixture was heated for )0 min. and then 
allowed to stand overnight at room temperature. On reducing 
the volume ^  vacuo % D-arablnose oxime separated. Recrystallisa- 
tion from aqueous ethanol gave white needles (5 g., 90f(>) m.po 159*
(lit. m.p. 159*]u
D^Arabitylamine * - PtOj (0.5 g*) was suspended in ethanol 
(loo ml.) and reduced with hydrogen. A solution of B-arabinose 
oxime (2 g.) in water (50 ml.) was then added, and the whole 
hydrogenated until the theoretical uptake of hydrogen was obtained 
(500 ml.). After removal of the catalyst the solution of 
D»arabitylamine was used directly as described below.
4-D-Arabitylamino-2,6-dlhydroxy-5~nitropyrimidine. =
The amine solution from the above experiment was treated with an
•thanolic solution (50 ml.) of 4-ohloro-2,6-dihydroxy~5~nitro-
pyrimidine (1.15 g.). The resulting mixture was allowed to stand
overnight at room temperature and a small amount of 4-amino-2 ,6=
109dihydro%y-5-Bltropyrimidiae (100 mg.) which separated was 
removed by filtration. Concentration of the filtrate to 20 ml.
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in vacuo and addition of ethanol (100 ml.) gave a white 
precipitate of nitropyrlmidino (1*5 which crystallised
from aqueous ethanol as white needles, m.p* 185* - 17o5*
[c,0*22 in 0*05 B-»HaOE](Found* C,)5.2# H,4o5i N,16*0. C^H^^N^Og 
requires C,)5*)$ H,4«6# N,18,3J5)*
This material was different from the corresponding 
D-ribityl pyrimidine*
lO-D-Arabityl-2,lO=dihydro-2-o%o-4,6 * 8rtrihydroxypyrimido 
[5»4-g]pteridine. - D-Arabltyl-2,6-dihydr6%y-5-aitropyrimldine 
(250 mg.) was dissolved in water (10 ml.) and was treated with 
B-eodium hydroxide solution (5 ml*). Sufficient solid sodium 
dithionite was added to reduce the nitro group and resulting 
colourless eolation was taken to pH4 with 25«hydrochloric acid 
solution. Alloxan (O*!) g.) was added to the cooled solution 
and the mixture was refluxed for 1 hr. and left overnight*
Yellow needles of the pyrimidopteridine separated (200 mg*, 679&) 
which were reoryetallised from N-hydrochloric acid, m*po y 525*
[a]p - 76* (c,0o20 in 0*05N*Na0H) (Pound; 0,41.6$ H,3o8$ N,21*2*
requires 0 ,41*6$ H,5»7 & 8 ,21*0^). 
2.4^Dihydroxy- 7 #8-dihydro»6-| D~arabo~tetrahy4roxybutyl 1 
pteridihe* • l-[2 *,6 **Dihydroxy-5*“nitro«4 **pyrinidinylamino]-l»
deoxy*h-fructose (1 g*) was dissolved in water (10 ml*) and Raney 
nickel sludge (approx* 0*5 g.) was added* The mixture was
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hydrogenated overnight when the theoretical volume of hydrogen 
(2ÔÔ mlc) was absorbed* A grey-white material separated and this 
was dissolved using 2N-sodium hydroxide solution (2 ml*)* The 
catalyst was removed and left overnight at 0*. A solid separated 
(400 mg*, 45^) and was purified by warming in water (10 ml*) which 
contained a trace of sodium dithionite* The compound proved to 
be the mono-sodium salt of the dihydropteridine (Founds Ci39©4$ 
H,4o7o C^QHjjN^O^Na requires C,39.0# H,4o2^). The dihydropteridine 
itself was unstable in air*
942,4,6-Trihydroxypteridine. - (a) To 5,6-diamino-2,4- 
dihydroxypyrimidino hemisulphate (6 g*) dissolved in w/w
sulphuric acid solution (72 ml*) at 90* was added ethyl glyoxylate
, ■ 1 0  T  ‘hemiacetal (6*6 g.). After 2 min* at 90*, water (300 ml*)
was added and the mixture left at 0*. The crystals and potassium 
carbonate (8*5 g*) were dissolved in boiling water (100 ml*)*
The potassium salt was filtered from the chilled solution, 
dissolved in boiling water, brought to pH4 with citric acid and 
recrystallised from water giving 2,4,6-trihydrqxyptoridine (509&) 
m*po360-380*(deo.).
-(b) l-[2•I6•-Pihydroxy-5'-nitro-4•-pyrlnidinylamino]-l-deoxy-i)- 
fructose (1 g*) was dissolved in water (10 ml*) and reduced as in 
the previous experiment. The dihydropteridine was dissolved as 
before and loft at room temperature for 3 days during which oxygen 
was continuously bubbled through the solution* A yellow colour
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formed and gradually intensified and on acidification with 
2N-hydrochloric acid solution yielded an orange solid (300 mg*) 
Rectystallisation and boiling with charcoal gave 2,4,6-trlhydroxy' 
pteridine which was identical to an authentic sample (see above) 
in infrared and ultraviolet spectra and on paper chromatography 
in various solvents*
Phthallmidoacetone* «= Potassium phthalimide (100 g*) 
was rcfluxed in dry xylene (lOO ml.) with chloroacetone (100 ml*)
in an oil bata at 120=130*. After 1 hr. a light brown syrup
resulted. The xylene anu excess ohloroacetone were removed 
in vaouo. The resulting oil solidified on cooling and was
crystallised from boiling water (6 l*i to give the product (70 g*^
50^ ; ,  m „ p „  117*
Aminoacetone Hydrochloride. = Phthallmidoacetone (100 g.) 
was heated with 20^ - hydrochloric acid solution (700 ml*) under 
reflux* After 1 hr. the mixture became homogeneous, and on
further boiling p^thalic acid began.to separate*- After 4 hr* the
reaction mixture was allowed to cool, the phthalic acid was
removed and the filtrate was taken to dryness vacuo, at 40-45*
Tho resulting syrup »as dissolved in twice its volume of warm 
absolute alcohol. A small amount of ammonium chloride which 
separated was removed* ' oXoeas other was added and on standing 
aminoacetone hydrochloride (25 47i^ ) separated as plates,
which wore washed with ether and dried over phosphorus pentoxlde*
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Aminoacetone Semicarbazone Hydrochloride. = Aminoacetone 
hydrochloride (38 g.) was dissolved In ethanol (250 ml*) and an 
aqueous solution (100 ml.) of semicarbazide hydrochloride (48 go) 
was added. After 2 hr. at 0® the white solid (53 95^) which
separated was filtered off and was washed with ethanol. Recrystall=
97 _isation from aqueous ethanol gave needles, m.p. 212® (lit.  ^ 212*j*
4-Acetonylamlno-2,6-dihydroxy-5-nitropyrimidine semi-
carbazone. - Aminoacetone hydrochloride semicarbazone (4*62 g. - 
.
2 eq.) was suspended in an ethanolic solution (40 ml.) of sodium 
(0.64 g. - 2eq.) and left at room temperature for 30 min. To 
this mixture was added an ethanolic solution (60 ml.) of 4-chloro-
2,6-dihydroxy-5-nitropyrimidine (2.66 - 1 eq.). Precipitation 
occurred almost immediately and the mixture was well stirred*
Water (20, ml*) was added and the yellow solid was filtered off. 
Roorystallisatlon from water gave the semicarbazone as needles 
(4.0 g., m.p. > 300» (Pound» C,)2.5« H.4.4| N,33o6o CeHjjN^Oj,,
0.3Ug0 require. 0,32.6* H,4«l* N,33.4^)«
4-Aoetonylamino=2,6-dihydroxy-S=nitropyrimidino. - 
4-Acetonylàmino-2,6-dihydroxy-5-ni1ropyrimidine semicarbazone (1 g.) 
suspended in B-hydrochloric acid solution (50 ml.) was kept at 
37* for 3 days. On cooling overnight at 0?, a solid separated 
(300 mg.). Concentration of the mother liquors gave a further 
300 mg* (Total 76^ ). Reczystallisation from water gave the
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pyrimidine as prisms, m*p. 27J® (Found; C,36o8$ H,5o7i N,24o2. 
C^HgN^Ojj requires C,36*8$ lI,5o5» N,24o5^)<»
4» 5-Dihydro-7-hydroxy-)-mothyl-ü-nitro-5-oxo-imidazo 
f1,2-c1pyrimidine. - (a) 4-Acetonylamino-2,6-dihydroxy-5-
nitropyrimidine semicarbazone (2 g.) was refluxed in 2N-hydro- 
chloric acid solution (50 ml.). On cooling a yellow solid 
separated. Recrystallisation from water gave the product as 
fine needles (1.2 g., 80]^ ), m.p. 265* (Found: 0,59.8# H,5o2# N,26o8o
CvHgN^O^ requires 0,40.0# H,2.9# #,2697^ ^*
(b) 4-Acetonylamino-2,6-dihydroxy-5=nitropyrimidine (lOO mg.) 
was refluxed in 2N-hydrochloric acid solution (10 ml.)* On 
cooling a yellow solid separated which was recrystallised from 
water as fine needles (60 mg., 64^), m.p. 265*. The product was
identical with the material prepared in method (a) in all
respects•
Hydrazinc Salt of 4*^ Acetonylamino-2,6-dihydroxy-5- 
nitropyrimidinehydrazone. - 4-Acetonylamino-2,6-dihydroxy-5- 
nitropyrimidine (4OO rag.) was suspended in ethanol (60 ml.) and 
excess hydrazine (0.I5 ml.) was added. On heating a gum formed 
which slowly dissolved* On cooling a white solid separated 
(400 rag.# 83^)* Reoryatallisation from water gave the 
hydrazone salt as micro needles, m.p. 3OO* (Found; C, 30.5$ 
8*4*8# N,40.2« Cl, 11^ QNg0^  . requires 0,30.6# H, 5* 1 # N,40.8^).
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7,8-Dihydro-2^4-Blhydro%y-6=methylpteridineo - (a)
Acetonylamino-2,6-dihydroxy-5-nitropyriinldine (JOO mg.) was 
suspended in water (2J ml.) and hydrogenated overnight with 
Raney nickel sludge (approx. 0.5 g*)* The theoretical uptake 
was absorbed (90 ml.). The solution was taken to pHl) with 
2N-8odium hydroxide solution and warmed. The catalyst was 
removed and a crystalline sodium salt separated on cooling the 
filtrate. Neutralisation with 2N-hydrochloric acid solution gave 
a jelly which on heating gave a yellow solid. Reczystallisation 
from water gave the dihydropteridine needles (16Ô mg.^ m.p. >
300* (Found; 0,46.8# H,4o5l N,51*0. Qg requires 0,46.7#
H,4o8| N,31.1^)o
(b) 4-Acetonylamino-2,6-dihydroxy-5"^l”tropyrimidine semicarbazone 
(400 mg.) was added to a suspension of Raney nickel (approx. 0.5 g*) 
in water (50 ml.) and the mixture was hydrogenated until 3 moles 
of hydrogen had been absorbedo The catalyst was 
removod and the filtrate was made 2N with respect to acetic acid 
and refluxed for 1 hr. The water and acetic acid were removed 
in vacuo leaving a yellowish oil. Crystallisation from water 
gave the dihydropteridine as yellow needles (100 rag., 40^). This 
material was identical with the product obtained from method (a).
2,4-Dihydroxy-6-ttethylpteridine. - (a) 7*8-Dihydro-2,4-
dihydroxÿ-6-methylptèridine (120 mg.) was dissolved in O.lN-sodlum
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hydroxide solution. Oo2M-potassium permanganate solution (2.2 ml.) 
was added giving a suspension of manganese dioxide in a faint 
green solution. The manganese dioxide was filtered off and the 
green colour destroyed by the addition of a trace of sodium 
dithionite. On acidification a white solid separated which 
reorystalllsed from water to give the pteridine as colourless 
needles (80 mg. 6?^)* m.p. 300* (Founds C,47oO| n,5ol# N,31o7o 
requires 0,47.2# H,3o4% N,31.5?^ ).
(b) The hydrazine salt of 4-acetonylamlno-2,6-dlhydroxy=5=nitro- 
pyrimidine hydrazine (200 mg.) was added to a suspension of 
Raney nickel (approx. 0.5 g*) in water (25 ml.) and the mixture 
was hydrogenated until the uptake of hydrogen was complete 
(24 hr.). The catalyst was removed and the filtrate was made 
2N with respect to acetic acid and refluxed for 1 hr. The water 
and acetic acid were removed in vaouo leaving a light brown gum 
which crystallised from a little aqueous ethanol. Recrystallisa­
tion from water gave the pteridine as colourless needles similar 
in m.pof ultraviolet and infrared spectra, and chromatography 
in various solvents with the material obtained from method (a).
Hydrazine Salt of l-[2•,6•-Dihydroxy-5 *-nitro-4•- 
pyrimidinyiaminol-l-deoxy-D-fruotose Hydrazone. - l-[2*,6* = 
uihydroxy-5*-nitro-4•-pyrimidinyiaminoJ-l-deoxy-D-fruetoee (500 
mg.) was suspended in ethanol (50 ml.) and excess hydrazine
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(OoI5 ml.) was added. The mixture was refluxed for 1 hr. and 
left overnight at room temperature. A yellowish solid (400 mg., 
75^) separated which could not be purified by crystallisation. 
m.p.^300*. Satisfactory analytioaüL data C'^ uld not be obtained 
but ultraviolet and infrared spectral analysis indicated that 
the correct compound had been prepared. Paper chromatography 
showed one spot in several solvents.
Cyclisation of the Kydrazine Salt of 1-f2*.6*-Dihydroxy 
-5•-nitro-4•-pyrimidinyiamino1-l-deoxy-D-fructosé Hydrazine. - 
Hydrazine salt of l-[2•,6*-dihydroxy-5*-nitro-4-pyrimidinylamino]- 
l-deoxy-D-fructose hydrazone (400 mg.) was dissolved in water 
(30 mlo). Raney nickel (approx. 0.5 was added and the mixture 
hydrogenated until uptake was complete. After the catalyst was 
removed, the filtrate was made 2N with respect to acetic acid 
and was refluxed for 30 min. The solution developed an orange 
colouration and removal of the water and acetic acid ^  vacuo 
gave an orange solid (I50 mg.). Purification by crystallisation 
was not possible.
2,3*4#5-Te trahydro-7-hydroxy-8-nitro-5-oxo imidazoF1.2-c] 
pyrimidine « - 2,6-Dihydroxy-4*-2*-hydroxyethylamino-5-nitropyrimidine 
(2 go) was rofluxed in N-hydrochloric acid (200 ml.) for I5 min.
On chilling, a white solid separated. Recrystallisation from 
water gave the imidazopyrimidine as needles (I.4 g., 70^) m.p.
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275*. (Founds C,55o45l H,3o7# N,25o5. CgE^N^O^.HgO requires
C#33.5i H,3o7i N,25o9?S)* This material was entirely different 
from the parent compound.
<. 1.2.8.10.11,12-Hexahy<iro-4•6=dihydro«2« 6-d ioxoimidazo f
flo2>2.5-ii byrimidor5c4-glpteridinee « 2,3,4#5-T®trahydro-7-
hy’droxy-8«nitro-5"OZoimidazo-[l#2-c]pyrimidine (500 mg.) was 
dissolved in O.lN-aodium hydroxide solution and the nitro group 
was reduced using solid sodium dithionite. When the reduction was 
complete, the pH of the solution was adjusted to 3 by the addition 
of 2N-hydrochloric acid solution. Alloxan (400 mg.) was 
immediately added, the mixture was refluxed for 1 hr. and left 
overnight. A yellow solid separated (600 mg., 92^)* Recrystalliaa< 
tion from N-hydrochlorio acid solution gave yellow needles, m.p.
> 325* (Found: 0,42.6$ H,3o25i N,29o2. 0^.O.5H20 requires
C.42.2» H,3,15» N,29.7^).
Oxidative Self-condensation of 8-Amino-2,3#4#5«tetrahydro- 
7-hydroxy-5-oxoimidazo(1.2-c1pyrimidine. - 2,3#4#5-Tetrahydro-7=
hydroxy-8-nitro-5*oxoimidazo[1,2-cJpyrimidine (500 mg.) was 
dissolved in 0.IN-sodium hydroxide solution and the nitro group was 
reduced as above. The solution pH was adjusted to 1 with 2N- 
hydroohloric acid and the mixture refluxed for 2 hr. and left 
overnight. An orange solid separated (300 mg.) and was reorystall- 
ised from water as orange needles, m.p. ^  325* (Founds 0,39.7#
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H,3.5l H,26.25î<)o
This material was different from the product prepared 
from the alloxan condensation, but no structure fitted the 
analytical data.
Paper Chromatography
Chromatograms were developed by the ascending technique 
the solvents being (a ), butan-l-ol-JB acetic acid (7x5)* (b),
3^ aqueous ammonium chloride, (C) propanol-l-ol^water = conco 
ammonia (d,0o88) (40:20%1) and were viewed in ultraviolet light 
of wave-lengths 254 and 3^5 mu.
Absorption Spectra
Infrared spectra were determined with a Grubb Parsons 
infrared spectrophotometer on Nujol mulls and KCl discs.
Ultraviolet spectra were determined with a Unioam SP600 
spectrophotometer on aqueous solutions of standard pH.
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In the previous section of this theeie, the cyutheeis of
l-[5•-amino-2•.6 *-dihydrogy-A *-pyrimidinylamino1-l°deoxy-D=erythro 
pentuloss (UCVt X - ^ - OH) has been described. This compound 
corresponds to the Amadori-rearranged product in Woygand's'
IShypothesis for the biosynthesis of pteridlnes.X
N
H M
X
H O  £«,
OH OH
H M
I
Crij_ CO(OHOH)^CH^OH
Attention was now turned to an investigation of a method 
for the preparation of the parent pyrimidine glycoside (LXIV)o 
Two ideas suggest themselves:
(a) Degradation of a suitable purine nucleoside.
(b) Direct synthesis.
The preparation of the pyrimidine glycoside (LXIV) by 
ring-opening of a purine nucleoside is of particular interest 
since purine derivatives have been identified as the starting 
materials in the biosynthesis of flavins and pteridlneso
The first part of this section has been devoted to studies
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of ring-opening in the purine nucleoside9 guanosineo 
The reasons for selecting guanoslne instead of 
zanthosine were threefold.
OH
H O  CH. R
OH O H
H = NHgt Guanosine 
R « OHs Xanthosine
(a) Goodwin^* has discovered that of the purine nucleosides, 
guanosine was the most effective precursor of riboflavin.
(b) The amino group of a purine9 pyrimidine or flavin can be 
smoothly converted to a hydroxy group by the action of dilute 
nitrous acid* An amino group can also be regarded as a
biogenetic precursor of a hydroxy group.
, . 60»61(c) As described in the Historical Section» Lawley and
his coworkers have described the alkylation of guanosine»
and on the basis of spectral studies; these workers have
suggested that ring-opening of the imidazole ring can occur
soreadily on treatment with alkalio
A re-investigation of the alkylation and ring-opening 
of guanosine was therefore undertaken using benzyl bromide 
as the alkylating agent.
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Treatment of guanoslne with benzyl bromide under mild 
conditions gave crystalline 7-”b©nzylguano3inium bromide 
(CXXIVi R « D-rlbosyl) as the principal producto Comparison 
of the ultraviolet spectra of 7*=’m0thyld©oxyguanosinium-5r*« 
phosphate methosulphate and quaternary salt (CXXIV§ R « 
D-ribosyl) in pH7 buffer indicated structural similarityo 
Acid hydrolysis of the quaternary salt (CXXÎVç R ® D«ribosyl) 
gave 7-ben?i/lguanin© (CXXV) ^ cbaraetsrised by analysis and
60»S1spectral comparison with 7-siethylguanin® (XLVIII)o
D-Ribos® was identified by running a spot of the reaction
mistur® on a paper chromatogram and spraying with aniline
1 08hydrogen phthalate,
C H ^ P k PK
Gr«a»ic»5(«c A
R CXXf V c x x v
Treatment of the quaternary bromid® with dilute sodium 
hydroxide solution gave 2-amino«5*-b©nzylamino«4*hydroxy-6-Dc= 
ribosylaminopyrimidine (CXX7I| R « D-ribosyl) which was 
partially purified on an anion exchange resino
Paper chromatography of this solution in various solvents 
showed that two spots were obtained in acidic solvent systems and
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only one in neutral and alkaline systems. Ultraviolet spectra were
obtained by eluting the spots from paper chromatograms and these
proved to be identical. Since a formyl derivative of pyrimidine
(CXXVIô R “ D^rlbosyl) could never survive the alkaline conditions
of the reaction» it was adduced that the sugar moiety in the
pyrimidine glycoside (CXXVXt R « U-ribosyl) must exist in two
forms - furanosyl (CXXVII) and pyranosyl (CXXVIIl) « in acidic
conditionso An example of two such isomers occurring together^
was mentioned in the Historical Section# pertaining to the
ssalkaline degradation products of Nebularine.
C H ,P k  j OH
H NI
R
C X X V I
MH.
mIEC----IH-C-OH& 0H C-CS YrH C -----:
CHjjOH
C X X V T l
mÏw c —IH<=C“»OHÎ
\H-C-OHi
1
CXKVIH
Acid hydrolysis of the pyrimidine glycoside (CXXVI^ R 
U-ribosyl) gave 2 »6-diamino-5~benzylamino=4"hydroxypyrlmidine 
(CXXVI# R • H)f the purification of which yielded only a gum 
which was characterised as a crystalline picrate derivative* 
D-Ribose was identified as above.
Removal of the benzyl group from pyrimidine glycoside 
(CXXVIi R • U^ribosyl) was aciiieved using sodium and liquid
amaonia** to give the unstable 2p 5-dlamlno«4~hydro%y=6-D-ribo8yl=
aminopyrimidine (CXXIXj R « D-rlbosyl). Immediate hydrolysis of
this pyrimidine gave 20 4»5«triamino-4-hydrozypyrimidine (CXXIXj
R « H) and D®ribose«
Condensation of this well-characterised pyrimidine
(CXXIXfi R » H) with biacetyl gave 2-amino-4-hydrozy=6gT-dimethyl«
pteridine (CXXX) which was identical in all respects with an
10»authentic sample.
OH OHOH
HH OH'i Me
R ( CXXX XXu
a
Pyrimidine glycoside (CXXIX) was acid labile as it under­
went an oxidative self-condensation similar to compounds of type 
(XXII) in the first part of this thesis»
Although some of the intermediates have not been character-» 
ised completely» it is obvious that guanosine had been successfully 
converted to the acid labile 2,$-diamino-d-hydroxy-6-D-ribo8ylz%i&c«*
pyrimidine (cXZIXi R ■ R-rlboayl).
In an attempt to make more of this material available for
further study» attention was now turned to the direct synthesis of 
a pyrimidine glycoside of type (LXIV)»
The proposed synthesis involved the condensation between 
5"-Mt'«>'4-chlorouracil (LXVI) and D-ribosylamine (CXXXI) with subsequent 
reduction of the )-nitro group of the product (CXXXIl).
OH
OHI HOCHi N H x
A  A . '  Ç ? H O t H i OH
LXVI C X X X I OH OH CXXXU
Time has only permitted the investigation of model 
reactions in this series » Since in the proposed condensationp 
the production of hydrogen chloride was expected and as glyoosyl^ 
amines are prone to rearrangement and self-condensâtion under 
acidic* conditions, it was decided to use an acetylated glycosyl» 
amineo
The literature offered 2»)»4#6-tetra-O-acetyl-(3-D=
110 ,glucopyranosylamine (CXXXIV» R »• NRg ) as the most suitable 
model sugar amine » This is derived from D-glucose and the 
preparative details of the various steps in its synthesis are 
reliable»
D-glucose wae acetylated to give l»2»)»4»6-penta-0- 
acetyl-D-gluooee^^^ which was then brominated in position 1 with
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111hydrogen bromide to give a-acetobromoglucose» This unstable
product was refluxed in methyl cyanide with sodium aside to give
112the corresponding P-azido compound (CXXXIVi R » % }  which was
then reduced with hydrogen in ethyl acetate over Adams platinum
110 ,catalyst to give the required p-amino compound (CXXXIV» R - HHj)
AcO CH
c x x x / v
OAe
Condensation between4-chloro-5‘"nitrouracil (LXVI) and 
2,)$4#6-tetra-O-acety1-p-D-glucopyranosylamine (CXXXIVi R • NHg) 
gave 2»6-dihydroxy-4-2 * #5 * t4* »6*-tetra-0-aoetyl-P-D-glucopyranosyl« 
amino-5-nitropyrimidine (CXXXV) as a yellow oil which could not 
be properly characterised. Ultraviolet and infrared spectra and 
paper chromatography indicated» however» that condensation had 
taken place» A by-product from this reaction was N»N-*a*-Di- 
(D-glucosyl)amine octaacetate probably formed by condensation 
of two molecules of 2,> )»4e6-tetra-O-acetyl-P-D^^glucopyranosylamine 
hydrochloride.
Acid hydrolysis of pyrimidine (CXXXV) gave 4-amlno-2»6=
104dihydroxy-5-nitropyrlmidine and D-glucose. This confirmed 
that pyrimidine (CXXXV) was a glycoside. Deacctylation of this 
pyrimidine glycoside in ethanol with liquid ammonia gave a
OH 109
OH
■o
■V 0«C A
4c o ' ! -----
Ù
N-^ OM 
CHj.CO {CHOH\CHjOH
CXXXV LXX
crystalllna pyrimidins-sugar compound (CXXXVl) from which 
tho sugar could not bo removed by acid hydrolysiso Reacotylatioa 
of this material gava a crystalline acotato which was different 
from tho acatylatad glycoside (CXXXV)o -
Tho crystalline compound (CXXXVl) gave colour tasts 
which indicated that glycoside (CXXXV) had undergone an 
Amadori r®arrangement on treatment with liquid ammonia. If this 
were the case p the pyrimidine (CXXXVI) should be identical with
1-[2 * 96 ®-dihydrory-5 *-nitro-4*-pyrimidinylamino]-l-d©03ty-D- 
fructose (LXX) produced by the condensation of 4*chloro-5“" 
nitrouracil and isoglucosamine as in the previous sectione It 
has not been possible^ howeverp to confirm beyond doubt the 
identity of these two materials or of the acetates prepared from
t h O H S o
liU
The occurrence of an Amador1 rearrangement in liquid 
ammonia solution ie most unusualp although it could be attributed 
to the presence of ammonium acetate in the reaction mixture 
functioning as a proton donor. It would seem that a detailed 
study of this problem is warranted, but it has not been considered 
further in this thesiso
. l l î
TABIE OP Rp VALUES AND ULTRAVIOLET ABSœPTIOH MAXIMA
IL ULTRAVIOLET
Compound (A) (B) (C) (D) (E) pHl pHlJ pH?
CXXIV 0.5 260 267 259
284 285 
CXXV - 250 282
CXXVIç R - D-ribosyl 0.)) 0.81 0.78 0.56 O.JJ 274 266
0.44 0.72
CXXVIt R - H 0.95 272 262
CXXVI; R ■ H-picrate 0.74 - •=
GXXIX» R - D-ribosyl 0.10 272 266
CXXIXi R - H 0.47 270 265
CXXX 0.60 0.54 251 249
322 358
D-Riboso 0.25 - -
CXXXV 0.60 0.70 228 220
320 336
LXXII; R - H 0.1 0.6 228 220
318 336
CXXXVl 0.1 228 220
320 341
Acetate of CXXXVl 0.6
0-CluooBo 0.2 0.9
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7-Benzyl-guanosinlum Bromide» - Guanoslne (2o5 So) 
was dissolved in N,N-dimothylformamide (25O mlo)o. Sodium 
bicarbonate (5 go) and redistilled benzyl bromide (2 mlo , 2 eqo) 
were added and the mixture was left for 20 hro at and then
for 1 day at 0*. Solid sodium bicarbonate was removed by filtra» 
tion and the filtrate was taken to dryness vacuo at 40**
Ethanol (100 mlo) was added to the residue, most of which 
dissolved, leaving unreacted guanosine which was filtered offo 
The filtrate was re-evaporated at 40* and the procedure was 
repeated with another portion of ethanol (100 mlo). Chloroform 
(150 mlo) was added giving a white hygroscopic solid (5o6 go) 
which was collected quickly, washed with chloroform (20 ml,) 
and dried iju vacuo over silica gel. Recrystallisation from 
methano1-ethyl acetate gave the bromide as needles (l«3 go, )2^) 
moPo 171® (dsco), -15o6*(water) (Pound: C,45o2| H,4o4d
N,15oO, requires C,44o9» H,4^4e N,15o5^,
7-Bensylguanine, - 7-Benzylguanosinlum bromide (Oo) go) 
was refluxed for 1 hr* with N-hydrochloric acid (I5 mlo), The 
reaction mixture on cooling gave 7-benzylguanine hydrochloride 
(O0I4 go) as needleso These were dissolved in water and the 
solution pH adjusted to 7 when 7-benzylguanine separated (OolO go) 
moPo^ 500® (Found: C,59o9l H,4o6| N,29*Oo ('i2%  1 0 requires 
0,59.7  ^ H,4o6j N,29
2-Amino® 5-benzyXamino®4»hydroxy®6-D-ribosylaminopyrimidinec 
7-BenzyIguanesiniun bromide (loO go) was dissolved in OolN- 
sodium hydroxide solution and left for 1 day at room temperatureo 
Two purification techniques were attemptedo
(a) The solution was passed down a column of a weakly acidic
ion-exchange resin (Amberlite loR.Co^O; form) till the eluate
114was free of pentose. The pH of the eluate was adjusted to S 
with dilute ammonia solution and the eluate taken to dryness 
in vacuo at 40® giving a white hygroscopic solid (0o46 go) which
I Iwas dried at 100® over phosphorus pentoxide Jji vacuo, SozhloV /
extraction with dry acetone wae carried out for 20 hr^
Evaporation of the extract gave a white solid (0,27 go)@
(b) A similar solution was run on to an Amberlite CoGo400 column
(formate form) at pHl2o Ammonium formate buffer (pH9) eluted 
the glycoside fractions which were bulked and evaporated to 
dryness in vacuo at 40®® Ammonium formate was removed by sublima­
tion at 60® in vacuo leaving a hygroscopic pink residue which 
could not be crystallised. Analytical purity was not reached in 
either case,
Paper chromatography in acidic solvent systems showed 
two spots, whereas chromatography in neutral or alkaline solution 
gave only one spot.
2,6-Diamino-5»benzylamino®4"hydroxypyrimidine, - 2-Amino® 
5-benzylamino®4-hydroxy-6-I)®ribo8ylaminopyrimidin8 (lOO mg,) was 
dissolved in N-hydrochloric acid (5 mlo) and left overnight at
57*0 On neutralisation with 2N-sodium hydroxide, a brown solid 
separated and was filtered off. Attempted crystallisation from 
ethanol gave a solid gum OoPo ) )00*o
2,6-Diamino=5-benzylamiao-4-hydroxypyrimidlne picrateo - 
Crude 2$6=diamino=5=benzylamlno=4-hydroxypyrimidine was dissolved 
in warm 0.IN-hydrochlorio acid and a warm aqueous solution of 
picric acid in approx. equimolar quantity, was added and the 
mixture left overnight. Yellow needles separated and were 
recrystallised from water m.po 267®. This picrate exploded on 
heating and thus, gave faulty analytical data.
2,5-Diamlno=4=hydroxy=6»D=ribosylaminopyrlmidine. -
2-Amino=5=bengylamino-4-hydroxy=6-D-ribo8ylamlnopyrimidine (Oo 5 
go) was dissolved in liquid ammonia (10 ml.) and was added portion* 
wise over a period of 3 ai^to sodium (0.4 go) dissolved in 
redistilled liquid ammonia (lOO mlo). The mixture was stirred 
during the addition and for a further 6 min. Addition of 
solid ammonium chloride (1 g.) terminated the reduction and 
destroyed the deep blue colouration. The mixture was left: • Tovernight at room temperature. The cream residue was dissolved 
in water (25 ml.) and chromatographed by passing down a 
column of Amberlite I.R.C as described before. A white solid 
(0,2 g.) was obtained which contained a little sodium chloride.
2.5*6»Trtamino«=»4°hydroxypyrimidineo - Crude 2,5-
diamino-4-hydroxy-6-D-ribosylaminopyrimidine (l g.) was dissolved
in OolN«sulphuric acid solution (50 mlo) and warmed on a steam-
bath for )0 mine No attempt was made to isolate the free base
and the solution was used directly for the next experiment.
2-Amino-6,7=dlmethyl-4=hydroxypt@ridlne. - Excess
biacetyl (0.1 go) was added to the solution obtained from the
above experiment and the mixture was left overnight at 57*»
Neutralisation with 2K-sodium hydroxide solution gave a yellow
precipitate which was collected. Crystallisation from aqueous
ammonia solution gave off-white needles (500 mg.) m.po > 500®.
This material was identical in all respects with an authentic
109sample of this pteridine,
D-Ribose. - In each hydrolysis of the three pyrimidine
glycosides described above, a spot of the hydrolysate was examined
by paper chromatography in solvent (a ) and the D-ribose spot
developed as a teown stain by spraying with aniline hydrogen 
1 oephthalate in ^-butanol.
112Tetra-0=acetyl=p-D-glucopyranosylazideo » a-Aoetobromo- 
111glucose ( 1 0  g o )  and finely powdered sodium azide (5 g.) in 
methyl cyanide (50 ml.) were heated on a steam-bath for 4 hr.
Water vapour was excluded from the reaction. Sodium bromide and 
excess sodium azide were removed and the filtrate was taken to a 
gum by evaporation in vacuo. Crystallisation from methanol
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mlo) gave needles (6 go, 665^ ) moPo 1)0* [lit,, 129*].
110Tetra«°0-acetyl°P«=>D-glucosopyranosylaminQo « Tetra-0- 
ac0tyl-p»D-gluoo3opyranosylazide (5 go) dissolved in ethyl 
acetate (150 ml.) was shaken with Adams platinum catalyst 
(250 mgo) under hydrogen for 2 hr. The catalyst was removed 
and the filtrate was taken to a clear oil by evaporation in 
vacuoo Crystallisation from ethanol gave needles (4 g,» 869^ ) 
m.po 126* [lit., 126*].
The progress of this hydrogonolysis was followed by 
infrared spectroscopy which shon&d the gradual disappearance of 
the azide absorption band.
Attempts to Condense Acetylatod Glycosylamines with 
4"Chloro-2,6-dihydro%y-5-nitropyrlmldine.
2o6~Dihydroxy=5*nltro=6=t0tra=O=aGetyl-P=gluco8ylamlno™ 
pyrimidine. = 4-Chloro=2p6-dihydroxy=5-%itropyrimidine (500 mg.) 
was dissolved in ethanol (50 mlo) and added to an ethanolic 
solution (50 mlo) of 2,5,4p6-tetr&-0-8cetyl=p=D=glucopyrano8ylamin@ 
(I08 g., 2 oq.) and heated on a steam-bath for 10 mln* On cooling 
a white solid separated which crystallised from ethanol as 
needles, m.p© 216*, [a]^— 85* (ethanol) and was identified as 
N,N-*G*-Di-(jD-gluco8yl)amine octaacetate [littt* m.po 215-216*,
[aJjj - 67* (chloroform)j. On concentration of the solution, 
more octaacetate separated. An oil remained which could not 
be crystallised. Purification using an anion exchange column
lie
did not give a crystalline product. This material showed
ultraviolet absorption, with maxima at )20 mu (pHl) and at
536 mu (pH13), characteristic of a 5-nitrouracil derivative.
Paper chromatography showed the presence of a single component
with Rp " 0.8 in solvent (a ) and Rp • 0.7 in solvent (B). The
data suggests that the required compound has been formed.
Hydrolysis of 2,6-J)ihydroxy-5‘°nitro-6-tetra-0«=^acet.vl^ D«=
glucoaylamlnop.yrimidine. - 2,6-Dihydroxy-5«nitro«6-tetra-0-acetyl
D-glucosylaminopyrioidine (0.5 ml.) as the crude oil from above,
was refluxed in 0.2N-hydrochloric acid solution (5 ml.) for
5 min. Paper chromatograms in two solvent systems showed that
1044-amino=2BO=dihydroxy=5-nitropyrimidine and D-glucose wore
formed. The sugar was detected by spraying with aniline
1 06hydrogen phthalate solution and the pyrimidine by examining 
the chromatogram with ultraviolet light of wavelength 254 mu.
Rp Solvent System Oil Hydrolysate Base D-Glucose
(A) Oo0 0.1 0.1
0o2 0.2
(B) 0*7 O06 O06
0.9 0.9
A solid separated (100 mg.) and was identified as 
4-amino-2,6-dihydroxy-5=nitropyrimidine by infrared spectrum with
119
104an authentic sample.
Attempted Deacetylation of above Glycoside. - An
ethanolic solution of liquid ammonia (1 :1 * viv) (50 ml,) was
added to the crude oil of 2,6-dihydrozy-5-nitro-6-tetra-0-acetyl
-D-glucosylaminopyrimidine made as above from 4=chloro=5-nitro=
uracil (500 mg,) and the mixture allowed to stand for $ days at
room temperature. A solid separated which was recrystallised
from ethanol as needles (500 mgo) mop. 210* (Pound: C,31oOg
H,5o5* N,17.7o C10B14B4O11.NHg.2H2O requires 0,31.01 H,5o5#
N,16ol^)o The ultraviolet absorption spectrum showed maxima
at 320 mu (pEl) and 541 mu (pH15) indicative of a 5-%itro-6°
alkylaminouracil derivative. A faint purple colouration was
77obtained in alkaline solution with o-dinitrobenzene.
Attempted hydrolysis of this material using hydrochloric 
acid solution (O.lN or N) brought about no apparent change as 
judged by paper chromatograms0
Reacetylation of this material (100 mg.) was carried out 
as follows. The pyrimidine was dissolved in pyridine (6 ml.) 
and acetic anhydride (6 ml.) and left overnight. As the 
starting material dissolved, other crystals separated. Excess 
acetic anhydride was destroyed by addition of ethanol (50 ml.) 
and the now homogeneous solution was left for 2 hr. The mixture 
was taken to a gum by distillation jn vacuo and taken down twice 
with ethanol (2 x 10 ml.). Crystallisation from ethanol«petrol©um
120
ether (4O-60) gave colourless needles (100 mg.) mop. 180®
(Founds 0,4606} 3,4o6*9o
Comparison of this acetate with a sample prepared by 
acstylating l=[2*96'-dihydrozy=5*=nitro=4*-pyrimidinylamino]= 
l°d@oxy°D=fructos© did not provide conclusive proof of the 
identity of these compounds.
Paper Chromatography
Chromatograms were developed by the ascending technique, 
the solvents being,(a ), butan-l-ol-5N“ac©tic acid (7*3)» (3),
3^ aqueous ammonium chloride, (C), propan-l-ol«water-conc. 
ammonia (d,0o88) (40s20s1),(D). Wyatt's solvent, and (e), butan« 
=-l“Ol«ethanol-water (50*15*55) and were viewed in ultraviolet 
light of wavelength 254 and 3^5 ati»
Absorption Spectra
Infrared spectra were determined with a Grubb-Parsons 
infrared spectrophotometer on Nujol mulls and KCl discs.
Ultraviolet Spectra were determined with a Unicam SP600 
spectrophotometer on aqueous solutions of standard pH.
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